GATA transcription factors during testicular development and disease by Ketola, Ilkka
GATA TRANSCRIPTION FACTORS
DURING TESTICULAR DEVELOPMENT
AND DISEASE
Ilkka Ketola
Program for Developmental and Reproductive Biology
Biomedicum Helsinki
University of Helsinki
Finland
and
Pediatric Graduate School
Hospital for Children and Adolescents
University of Helsinki
Finland
ACADEMIC DISSERTATION
Helsinki University Biomedical Dissertations No. 24
To be publicly discussed with permission of
The Medical Faculty of the University of Helsinki,
in the Niilo Hallman Auditorium of the Children’s Hospital,
on 21 February, 2003, at 12 noon
Helsinki 2003
Supervisors
Professor Markku Heikinheimo
University of Helsinki
and
Professor Juha S. Tapanainen
University of Oulu
Reviewers
Professor Raimo Voutilainen
University of Kuopio
and
Docent Jorma Palvimo
University of Helsinki
Official opponent
Professor Heikki Ruskoaho
University of Oulu
ISBN 952-91-5575-1 (paperback)
ISBN 952-10-0956-X (PDF)
ISSN 1457-8433
Helsinki University Printing  House
Helsinki 2003
To my family

5Contents
CONTENTS
1 ORIGINAL PUBLICATIONS ................................................................................................... 7
2 ABBREVIATIONS .................................................................................................................... 8
3 ABSTRACT ............................................................................................................................... 9
4 INTRODUCTION ..................................................................................................................... 11
5 REVIEW OF THE LITERATURE ........................................................................................... 13
5.1 Testicular development and function .......................................................................... 13
5.1.1 Fetal period ......................................................................................................... 13
5.1.2 Postnatal period .................................................................................................. 15
5.2 Genes essential for early gonadal development ........................................................ 18
5.2.1 Establishment of the urogenital ridge .............................................................. 18
5.2.2 Testis differentiation .......................................................................................... 19
5.2.3 Anti-testis genes ................................................................................................. 20
5.2.4 Other genes important for gonadal development ........................................... 20
5.3 Diseases of the human testis ....................................................................................... 22
5.3.1 Hypogonadism ................................................................................................... 22
5.3.2 Tumors ................................................................................................................ 23
5.4 The GATA-family of transcription factors .................................................................. 23
5.4.1 Mode of action .................................................................................................. 24
5.4.2 Vertebrate GATA factors ................................................................................... 25
5.4.3 Friends of GATA, FOG-1, and FOG-2 .............................................................. 28
5.4.4 Clinical implications of GATA and FOG families ............................................. 28
5.5 Role of apoptosis in testis ............................................................................................ 29
6 AIMS OF THE STUDY ............................................................................................................ 31
7 SAMPLES AND METHODS .................................................................................................. 32
7.1 Tissue samples ............................................................................................................... 33
7.1 1 Human testicular samples ................................................................................. 33
7.1.2 Animal samples, models, and cell culture ........................................................ 33
7.2 Experimental methods ..................................................................................................... 34
7.2.1 RNase protection assay ..................................................................................... 34
7.2.2 Northern hybridization ...................................................................................... 34
7.2.3 mRNA in situ hybridization .............................................................................. 34
7.2.4 Western blotting ................................................................................................. 34
67.2.5 Immunohistochemistry ....................................................................................... 35
7.2.6 In situ DNA 3’-end labeling .............................................................................. 36
7.2.7 Transfections ....................................................................................................... 36
7.2.8 Statistics ............................................................................................................... 36
8 RESULTS AND DISCUSSION .................................................................................................. 37
8.1 Expression of GATA and FOG factors during testicular development .................. 37
8.1.1 Expression in urogenital ridge and fetal testis (I-IV) ...................................... 37
8.1.2 Fetal expression of GATA and FOG factors in relation to
         gonadal developmental genes ......................................................................... 39
8.1.3 Expression in postnatal testis (I-III) ................................................................ 40
8.2 Regulation of testicular GATA factors ........................................................................ 43
8.2.1 Cell culture (I) ....................................................................................................... 43
8.2.2 Regulation of GATA-4 and GATA-6 in vivo (I) ............................................... 44
8.3 Role of GATA and FOG factors in testicular function ............................................... 46
8.3.1 GATA-4 regulating inhibin α gene (I) ............................................................... 46
8.3.2 FOG-1 and FOG-2 repression of inhibin α gene activation by GATA-4 ........ 47
8.3.3 GATA-4 and FOG-2 required for early testicular development ...................... 48
8.3.4 Several gonadal genes regulated by GATA-4 and FOG proteins ................. 49
8.3.5 The role of GATA-4 in hypothalamus and pituitary ....................................... 51
8.3.6 Apoptosis and cell proliferation in fetal human testis (IV) ............................. 52
8.4 GATA-4 and diseases of human testis ........................................................................ 54
8.4.1 Developmental disorders (II) ............................................................................ 54
8.4.2 Tumors (II) ............................................................................................................ 56
9 CONCLUSIONS ........................................................................................................................ 58
10 ACKNOWLEDGEMENTS ..................................................................................................... 59
11 REFERENCES ......................................................................................................................... 61
Contents
7Original Publications
1 ORIGINAL PUBLICATIONS
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GATA-6 in developing mouse testis. Endocrinology 1999 140:1470-1480.
II) Ketola I, Pentikäinen V, Vaskivuo T, Ilvesmäki V, Herva R, Dunkel L, Tapanainen JS, Toppari J
and Heikinheimo M. Expression of transcription factor GATA-4 during human testicular
development and disease. Journal of Clinical Endocrinology and Metabolism 2000 85:3925-3931.
III) Ketola I, Anttonen M, Vaskivuo T, Tapanainen JS, Toppari J and Heikinheimo M. Developmental
expression and spermatogenic stage specificity of transcription factors GATA-1 and GATA-4 and
their cofactors FOG-1 and FOG-2 in the mouse testis. European Journal of Endocrinology 2002
147:397-406.
IV) Ketola I, Toppari J, Vaskivuo T, Herva R, Tapanainen JS and Heikinheimo M. Transcription
factor GATA-6, cell proliferation, apoptosis and apoptosis related proteins bcl-2 and bax in human
fetal testis. Journal of Clinical Endocrinology and Metabolism, in press.
In addition, some unpublished data are presented.
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2 ABBREVIATIONS
AR Androgen receptor
DHT 5α-dihydrotestosterone
E Embryonal day
EDS Ethylene dimethanesulfonate
EMSA Electrophoretic mobility shift analysis
FGF-9 Fibroblast growth factor-9
FOG Friend of GATA
FSH Follicle stimulating hormone
GnRH Gonadotropin-releasing homone
hCG Human chorionic gonadotropin
hpg Hypogonadal
IHC Immunohistochemistry
Insl3 Insulin-like hormone-3
ISH In situ hybridization
LH Luteinizing hormone
MIS Müllerian inhibiting substance
mRNA Messenger ribonucleic acid
P Postnatal day
PGC Primordial germ cell
SCF Stem cell factor
SCOS Sertoli-cell-only syndrome
SF-1 Steroidogenic factor-1
SRY Sex-determining region of chromosome Y
StAR Steroidogenic acute regulatory protein
UGR Urogenital ridge
WT-1 Wilms’ tumor gene-1
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3 ABSTRACT
Members of the GATA family of zinc-finger transcription factors are expressed in a variety of
tissues. They are well conserved through evolution and are considered to play critical roles in
regulating the development and function of several organisms from flies to mammals. The six
members of the GATA family are called GATA-1 to GATA-6. They share high structural homology
among their zinc-finger regions that are functionally indispensable. Friends of GATA, FOG-1 and
FOG-2, are multitype zinc-finger proteins that modulate the transcriptional activity of GATA factors.
GATA factors are essential for hematopoiesis, ventral morphogenesis, heart development, and
endoderm formation. GATA-1, GATA-4, GATA-6 and their cofactors FOG-1 and FOG-2 are expressed
in the gonads. In humans and in experimental animal studies they have been linked to hematological
diseases and tumor formation. Given the developmentally non-redundant role of GATA-1, GATA-
4, and GATA-6 and their cofactors FOG-1 and FOG-2, and their abundant expression in gonads,
this study aimed to further evaluate their role in testicular development and function.
GATA and FOG mRNAs and proteins were detected by Northern and Western blotting, and
temporospatial expression was studied by use of mRNA in situ hybridization and
immunohistochemistry. Cell cultures were employed in order to study in vitro hormonal regulation.
Testicular samples from genetically hypogonadal mice, after GnRH receptor antagonist-treatment
and after chemical abolition of Leydig cells, served for the study of hormonal regulation in vivo.
The gene activation studies utilized in vitro co-transfections.
Transcription factor GATA-4 and FOG-2 were expressed in the undifferentiated mouse urogenital
ridge, implying a role for them even during the earliest stages of testicular development. Expression
of GATA-4 persisted in Sertoli and Leydig cells throughout the fetal and postnatal development.
Gonadotropins and androgens regulated GATA-4, but their action was not required for basal
expression of GATA-4 at any time of development. GATA-4 regulated the inhibin α gene that is a
crucial hormone subunit for proper spermatogenesis. Human Sertoli and Leydig cell tumors
exhibited robust GATA-4 expression, suggesting a role for GATA-4 in tumorigenesis or in associated
processes such as enhanced cell proliferation. FOG-2 expression ceased in fetal testis, but became
upregulated in the somatic cells of the newborn testis. Later, along with advancing spermatogenesis,
FOG-2 was downregulated in somatic cells, but its expression reappeared stage-specifically in
germ cells.
In human fetal testis, the expression pattern of GATA-6 partially overlapped with that of GATA-4.
Differences in the expression of these related factors may reflect distinct functions in the human
testis. The early expression of GATA-6 suggests that it may play a role in testicular differentiation.
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GATA-1 was not expressed in mouse fetal testis. In contrast, FOG-1 was expressed in fetal Sertoli
cells, indicating that it may act as a cofactor for GATA-4 during late fetal testicular development.
Postnatally, GATA-1 and FOG-1 were co-expressed in Sertoli cells. In adult testis, their expression
was stage-specific, whereas the expression of GATA-4 was constant regardless of the stage of the
spermatogenetic wave. Thus, in mouse postnatal testis, FOG-1 most likely modulates the
transcriptional activity of GATA-1.
In conclusion, testicular GATA factors are expressed in a distinct, but partially overlapping manner
during testicular development from the fetal period to adulthood. GATA-4 is hormonally regulated
and regulates the inhibin α gene. The expression pattern of testicular GATA factors suggests that
they are important regulators of testicular development and function. FOG-1 and FOG-2 are likely
to modulate their actions.
11
Introduction
4 INTRODUCTION
Precise gene expression is the basic requirement for development and growth of living organisms.
Our genetic information is stored in DNA, which is replicated in order to perpetuate genetic
material from one generation to the next. Gene expression is the transformation of DNA information
into functional molecules. Transcription, synthesis of RNA from a DNA template, is the first stage
of gene expression and the principal stage at which it is controlled. Transcription factors are
proteins that regulate transcription through complex mechanisms.
The members of the GATA family of transcription factors are regulatory proteins that control gene
expression and developmental processes in various tissues. They are well conserved through
evolution from yeast to mammals. Vertebrates possess six known GATA factors, GATA-1 to
GATA-6. These are essential for normal hematopoiesis, heart development, and lung and gut
morphogenesis. They are expressed in a distinct but partially overlapping manner in a number of
tissues, including the gonads. Function of the GATA factors is modulated by their interaction
with other transcription factors, transcriptional co-activators, and co-repressors. The FOG proteins
FOG-1 and FOG-2, as the best characterized group of cofactors, either enhance or repress the
activity of GATA factors depending on cellular context. Besides evolutionarily conserved
expression patterns, GATA and FOG proteins regulate gene expression in a functionally conserved
manner.
In all vertebrates gonadal development is remarkably similar. Development of the testis or ovary
from a bipotential gonadal primordium is a process common to mammals, birds, and reptiles. In
mammals, several genes are known to be important for sex determination. Among these, the Y-
linked testis-determining gene SRY determines the sexual fate. The presence of SRY in the genital
ridge triggers a differentiation cascade that eventually results in testis development. Mutations
that adversely affect the function of SRY protein are responsible for disorders associated with
male-to-female sex reversal. Genetic analyses of human gonadal dysgenesis and animal studies
have revealed that sex determination results from a complex interplay between a number of different
genes.
Following sex determination, fetal testis produces hormones that ensure development of the male-
type ductal system and external genitalia. At puberty, major morphological changes occur within
the testis. Supportive cells, namely Sertoli cells, proliferate, testes grow in size, and steroid-
producing Leydig cells mature, reactivating the production of testosterone. These changes are
aimed at facilitating germ cell proliferation and subsequent sperm production. Under the influence
of gonadotropin-releasing hormone (GnRH), the pituitary gonadotropins FHS and LH regulate the
postnatal function of testes. Inhibin, secreted from Sertoli cells, and testosterone, as well, inhibit
by feedback mechanism gonadotropin secretion.
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Gene expression data provide an important resource for defining gene function and for identifying
hierarchies and networks of genes that regulate specific developmental programs. Testicular
development is a tightly regulated process, requiring temporally and spatially controlled expression
of a number of genes. Those genes act in concert in a manner that subsequently results in the
adult-type, functionally mature testis. GATA factors are involved in various developmental
processes. The study assessed the expression of gonadal GATA proteins and their cofactors
during testicular development and studied their expression during normal development as well in
developmental testicular diseases and in tumors.
Introduction
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5 REVIEW OF THE LITERATURE
5.1 Testicular Development and Function
The gonad arises as an identical primordium in all embryos and has the capacity to develop into
either testis or ovary. The sex chromosomes control differentiation of the gonads. In mammals, the
genetic sex of the embryo is established at fertilization with the inheritance of an X or Y chromosome
from the father. Gonads of an XY individual develop as testes and those of XX as ovaries. The
development of the internal genitalia duct system and external genitalia is determined by the
hormones and hormone-like substances produced by the developing gonads. Testosterone and
Müllerian inhibiting substance (MIS, also known as anti-Müllerian hormone, AMH), both secreted
by the fetal testis, are needed for development of the male phenotype. Absence of these hormones
leads to female-type sexual differentiation (Figure 1).
The testis is comprised of four cell lineages: the germ cells, connective tissue cells, steroid-
producing cells, and supporting cells such as Sertoli and myoid cells.  Sertoli and germ cells
surrounded by myoid cells form seminiferous tubules in which the spermatogenesis takes place.
Before puberty, they are called testicular cords. In the interstitium, between the tubules, Leydig
cells are the steroid-producing cells (Figure 2).
5.1.1 Fetal period
The gonads appear as a paired structure within the intermediate mesoderm. This region is called
the urogenital ridge and gives rise to the adrenals, kidneys, and gonads. The sub-region of the
urogenital ridge where the gonad arises is called the genital ridge (Capel 2000). The epithelium of
the coelomic cavity lines the urogenital ridges and serves as the source of multiple gonadal cell
lineages (Karl and Capel 1998, Schmahl et al. 2000). The ductal system arises from a structure
adjacent to the genital ridge called mesonephros that regresses during embryonal development, in
the mouse by the embryonal day (E) 12.5.In the mouse, primordial germ cells (PGCs) are first seen
in the yolk sec at E7 (Ginsburg et al. 1990). The exact cellular origin of PGCs is unknown. Their
ancestors are thought to arise from a pool of epiblast cells at E5-6.5. PGCs migrate to the gonadal
part of the urogenital ridge and enter that area between E9.5 and E11, and they may contribute to
Sertoli cell differentiation (Adams and McLaren 2002). Primordial germ cells proliferate mitotically,
yielding a total of about 20 000 cells from the initial pool of 50 cells (McLaren 2000). PGCs
differentiate to gonocytes (prespermatogonia) that undergo mitotic arrest until birth when they
resume proliferation (Sutton 2000, de Rooij 2001).
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Male and female mouse genital ridges are morphologically identical at E11. During that time, cells
of the coelomic epithelium proliferate intensively and migrate into the undifferentiated gonad.
Those cells differentiate to Sertoli cells that surround germ cells to form testicular cords (Karl and
Capel 1998). After the initial cord formation at E12.5, it is possible to distinguish the sex of an
embryo by morphology (Kaufman and Bard 1999). Sertoli cells are believed to act as the organizing
center of the male gonad, and are essential for normal fetal testicular development (Magre and Jost
1984, Magre and Jost 1991, Buehr et al. 1993, Martineau et al. 1997, Merchant-Larios and Moreno-
Mendoza 1998, Schmahl et al. 2000, Yao and Capel 2002). Leydig cell precursors originate from the
adjacent mesonephros and migrate into the genital ridge by E11.5 (Buehr et al. 1993, Merchant-
Larios and Moreno-Mendoza 1998), or they are derived from the cells of the coelomic epithelium
(Karl and Capel 1998, Yao and Capel 2002).
Figure 1. Development of the internal genitalia of the male and female from indifferent gonadal
primordia. Fetal testes produce MIS and testosterone. MIS causes the regression of Müllerian ducts, and
testosterone and its derivative dihydrotestosterone are required for the development of male-type external
genitalia (Rey and Picard 1998).
15
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The mesonephros regresses during embryonal development. In males, however, it gives rise to
rete testis, epididymis, and mesonephric (Wolffian) ducts. The rete testis forms a collecting drainage
system continuous with the testicular cords (seminiferous tubules in the adult). The mesonephric
(Wolffian) ducts give rise to the epididymis and other ducts which are needed for maturation,
nutrients, fluid, and delivery of sperm (Sainio et al. 1997). Testosterone produced by Leydig cells
promotes the differentiation of Wolffian-duct derivatives (Rey and Picard 1998). The Sertoli-cell
product MIS induces the regression of paramesonephric (Müllerian) ducts, which are the
progenitors of female oviducts, uterus, and the upper portion of the vagina (Figure 1) (Behringer
et al. 1994).
The testis is differentiated, and testicular morphology is clearly recognizable by E13.5. The testes,
still situated in the upper lumbar region, begin to descend, guided by gubernaculum testis into the
pelvis and eventually into the scrotum (Hutson 1985, Hutson et al. 1997, Kubota et al. 2002).
Around E14.5, testis is encapsulated by the fibrous tunica albuqinea, and the external genitalia are
differentiating. By E17.5, the testes and internal genital duct system are similar to those in the
newborn (Kaufman and Bard 1999, Kaufman 2001) (Table 1).
5.1.2 Postnatal period
The testis of a newborn or an infant is a functionally immature organ. Postnatal development of
the testis aims at a functionally/sexually mature organ capable of producing spermazoa (sperm)
and testosterone.
During the postnatal period, the number of Sertoli cells increases significantly. Sertoli cell
proliferation is most active at puberty, and by adulthood, fully differentiated Sertoli cells finally
cease proliferation (Orth 1982, Cortes et al. 1987, Vergouwen et al. 1991, Vergouwen et al. 1993,
Table 1. Timeline for mouse and human testis differentiation. (Data from Carlson 1999, Kaufman and
Bard 1999).
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Sharpe et al. 2000). They are essential for spermatogenesis, and their proliferation is required to
provide the structural and functional framework over which germ cells will subsequently proliferate
and differentiate (Griswold 1998, Chemes 2001). Immediately after birth, gonocytes differentiate
into spermatogonia. At puberty, spermatogenesis begins, and spermatogonia differentiate into
mature spermatozoa (Figure 2) (de Kretser et al. 1998, de Rooij 2001). The number of Leydig cells
remains fairly constant from the late fetal period throughout infancy. In early puberty, Leydig cells
initiate their proliferation and differentiate into mature adult-type testosterone-producing cells
(Nistal et al. 1986, Habert et al. 2001).
The main regulators of testicular function are gonadotropins, follicle stimulating hormone (FSH)
and luteinizing hormone (LH) (Figure 3). These are secreted from the pituitary gland under the
control of hypothalamic gonadotropin-releasing hormone (GnRH) (Griffin and Wilson 1998). Sertoli
cells are the main targets of FSH, and LH acts on Leydig cells. The fetal development of Sertoli and
Leydig cells is independent of gonadotropins. Postnatally, gonadotropins stimulate Sertoli
proliferation and are essential for normal differentiation and proliferation of adult-type Leydig
cells (Orth 1984, Baker and O’Shaughnessy 2001, Heckert and Griswold 2002).
LH stimulates Leydig cells to produce testosterone that is needed for normal spermatogenesis
(O’Donnell et al. 1996, McLachlan et al. 2002). The effect of testosterone and some other regulatory
factors on spermatogenesis occurs through Sertoli cells; disruption of Sertoli cell-germ cell
interactions leads to spermatogenic defects (Griswold 1998, Syed and Hecht 2002). The role of
FSH in male reproductive function is controversial.  While testosterone alone is sufficient to
maintain spermatogenesis, FSH may not be an absolute requirement for male fertility (Singh et al.
1995, Tapanainen et al. 1997, Plant and Marshall 2001).
The most important negative feedback regulators of gonadotropin secretion are testosterone and
inhibin. Testosterone acts mainly on the hypothalamus to suppress GnRH secretion (Griffin and
Wilson 1998). Sertoli cell-specific inhibin B, a heterodimer of the α and β-B chains, inhibits FSH
secretion from the pituitary gland (Plant and Marshall 2001). Inhibin B also serves as a efficient
positive marker for spermatogenesis and Sertoli cell function (Anderson and Sharpe 2000).
Testosterone and its metabolite estradiol have a suppressive feed-back effect on FSH secretion
(Griffin and Wilson 1998).
Whereas inhibin and testosterone act as endocrine regulators of gonadotropin secretion, activin
serves as a paracrine or autocrine regulator within the testis and pituitary (de Kretser et al. 2001).
Activin and inhibin share common β-subunits (A or B), and activin is a hetero- or homodimer of β-
chains. In the testis, activin modulates androgen production locally and has an influence on the
proliferation of Sertoli and germ cells. In the pituitary, activin enhances FSH secretion.
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Figure 2. Schematic view of testis structure and the differentiation program of male germ cells.
Above: General structure of the human testis. Lobules are filled with seminiferous tubules (only one
shown). Center: Cross-section of seminiferous tubules in which spermatogenesis takes place. Germ cells
are at different phases of differentiation in a given tubule. Sertoli cells are supportive cells facilitating
maturation of germ cells. Basement membrane and myoid cells separate seminiferous tubules from the
interstitial space. Below: Differentiation program of male germ cells. During the fetal period, primordial
germ cells differentiate into gonocytes, which differentiate into spermatogonia right after birth. At the
beginning of puberty, spermatogonia proliferate, to generate undifferentiated stem cells and to proceed along
the germ cell differentiation pathway into spermatozoa. Final panel modified from (Sassone-Corsi 1997).
18
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5.2 Genes Essential for Gonadal Development
Sex determination results from a complex interplay between different genes that are conserved in
many species. In mammals, several genes are known to be important for sex determination (Figure
4). They orchestrate the expression of genes that further mediate gonadal development. The
development of testis or ovary from a bipotential gonad throughout vertebrates is remarkably
similar.
5.2.1 Establishment of the urogenital ridge
The Wilms’ tumor suppressor gene WT-1 is required to establish the bipotential gonads and
kidneys (Kreidberg et al. 1993, Moore et al. 1999). This gene is expressed in gonads of both sexes
throughout fetal development (Pelletier et al. 1991b, Armstrong et al. 1993). Mutations in the WT-
1 gene result in complete XY sex-reversal, possibly through reduced SRY activity (Pelletier et al.
1991a, Barbaux et al. 1997, Hammes et al. 2001, Hossain and Saunders 2001).
Figure 3. Schematic view of the function of the hypothalamic-pituitary-gonadal axis. Solid lines
mark stimulatory, and dotted lines inhibitory effect. Le = Leydig cell; Se = Sertoli cell.
19
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Another gene expressed early is steroidogenic factor-1 (SF-1, also known as Ad4BP) (Lala et al.
1992, Morohashi et al. 1992), required for the formation of gonads and adrenals (Luo et al. 1994,
Achermann et al. 1999, Bakke et al. 2001). SF-1 is already expressed in the gonadal primordium of
both sexes, and in the Sertoli and Leydig cells of the testis (Ikeda et al. 1994, Shen et al. 1994,
Schmahl et al. 2000). It is not necessary for the initial formation of genital ridges; rather, it seems to
be required for the differentiation or the maintenance and growth, or both, of the somatic cells
already present there. Later, in the fetal testis, SF-1 regulates MIS in concert with WT-1 and SOX-
9 (Shen et al. 1994, De Santa Barbara et al. 1998, Nachtigal et al. 1998, Arango et al. 1999, Watanabe
et al. 2000, Shen and Ingraham 2002) and with a number of genes involved in steroidogenesis
(Parker and Schimmer 1997).
5.2.2 Testis differentiation
While WT-1 and SF-1 are required for the establishment of the urogenital ridges of both sexes,
SRY (Sex determining Region on Y chromosome) is a Y-linked gene that acts dominantly to trigger
testis development from indifferent urogenital ridge. Deletions or mutations of the SRY gene lead
to XY female development (Gubbay et al. 1990, Lovell-Badge and Robertson 1990, Sinclair et al.
1990, Gubbay et al. 1992, Hawkins et al. 1992). Even reduced SRY expression causes XY sex-
reversal or ovotestis (Laval et al. 1995, Nagamine et al. 1999, Hammes et al. 2001, Washburn et al.
2001). A female mouse carrying an SRY transgene develops a male (Koopman et al. 1991). No
target genes for SRY are known. SRY is first expressed in the male mouse urogenital ridge around
E10. Its expression peaks in Sertoli cells at E11.5 and declines sharply thereafter, indicating that
SRY initiates the differentiation of gonadal supporting cell precursors to develop as testicular
Sertoli cells rather than as ovarian granulosa cells (Hacker et al. 1995, Albrecht and Eicher 2001).
Sertoli cell signaling, in turn, is thought to be essential for further testis development (section
5.1.1).
A close relative of SRY is SOX-9. It is highly conserved at the amino acid level and is expressed in
testes of all vertebrates (Kent et al. 1996, Morais da Silva et al. 1996, Bowles et al. 2000, Nagai
2001). Mutations in SOX-9 result in XY sex-reversal, whereas ovarian development is normal,
demonstrating that SOX-9 is necessary for testis determination (Foster et al. 1994, Wagner et al.
1994, Koopman 1999). Furthermore, SOX-9 expression in ovaries results in female-to-male sex-
reversal (Huang et al. 1999, Bishop et al. 2000, Vidal et al. 2001). SOX-9 may represent an ancestral
sex-determining gene, and mammals have evolved SRY as a Y-linked switching mechanism (Nagai
2001). Based on expression pattern, SOX-9 serves as a putative target gene for SRY, although
definitive proof for this is still lacking. After Sertoli cell differentiation, SOX-9 regulates the
expression of MIS and SF-1 (De Santa Barbara et al. 1998, Shen and Ingraham 2002).
The Sertoli cell product MIS is not essential for testis formation but is required for the formation
of the male-type ductal system that eventually effects fertility (Behringer et al. 1994). MIS is
20
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expressed in Sertoli cells through fetal development (Munsterberg and Lovell-Badge 1991, Hacker
et al. 1995), and very low levels of AMH permit its function, which favors male-type development
(Arango et al. 1999). SOX-9 regulates MIS expression with co-ordinated interactions between SF-
1, WT-1, and GATA-4 (Foster et al. 1994, De Santa Barbara et al. 1998, Nachtigal et al. 1998, Arango
et al. 1999, Tremblay and Viger 1999). DAX-1 down-regulates MIS transcription, repressing the
synergistic action of SF-1 and WT-1 (Nachtigal et al. 1998).
5.2.3 Anti-testis genes
The nuclear receptor DAX-1, considered an anti-testis gene, is proposed to act as an SRY antagonist
(Swain et al. 1998, Yu et al. 1998). DAX-1 gene duplication results in male-to-female sex-reversal
(Bardoni et al. 1994, Zanaria et al. 1994), and mutations in DAX-1 lead to hypogonadotropic
hypogonadism (Muscatelli et al. 1994, Tabarin et al. 2000). DAX-1 is expressed in the gonads of
both sexes (Ikeda et al. 1996, Swain et al. 1996, Tamai et al. 1996). It is coexpressed with SF-1 along
the developing hypothalamic-pituitary-gonadal axis (Guo et al. 1995, Ikeda et al. 1996, Swain et al.
1996, Zazopoulos et al. 1997), and DAX-1 may repress SF-1-mediated activity in those organs (Ito
et al. 1997, Zazopoulos et al. 1997, Wang et al. 2001).
A member of the WNT family of secreted proteins, WNT-4 has been suggested to suppress male
development, because it down-regulates steroid production (Vainio et al. 1999). In human males,
duplication of the region of chromosome 1 that includes WNT-4 leads to sex-reversal (Jordan et al.
2001).
5.2.4 Other genes important for gonadal development
Fibroblast growth factor-9 (FGF-9) is widely expressed in mouse embryos, and male mice lacking
FGF-9 exhibit sex-reversal and phenotypes range from testicular hypoplasia to complete sex-
reversal (Colvin et al. 1999, Colvin et al. 2001). FGF-9 regulates SRY-dependent processes such as
cell proliferation and migration into the gonad, and Sertoli cell differentiation. Mouse knockout
studies have revealed several transcription factors that may play important roles in gonadal
development; these include Lim1, Lhx9, Emx2, and M33 (Shawlot and Behringer 1995, Miyamoto et
al. 1997, Katoh-Fukui et al. 1998, Birk et al. 2000). Their gonadal phenotype varies from complete
gonadal agenesis to sex reversal. More profound studies are needed to evaluate their function in
gonadal development.
For normal spermatogenesis, the correct gonadal position is essential. Disruption of the INSL-3
gene (also known as relaxin-like factor) causes bilateral cryptorchidism, i.e., failure of the testis to
descend from its embryonal retroperitoneal position into the scrotum (Zimmermann et al. 1999,
Adham et al. 2000).
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The genes described herein represent some of the most important genes known to be involved in
sex-determination and gonadal development. Many genes have sexually dimorphic expression
patterns in the gonad, and some of these undoubtedly contribute to testis formation and function
(Wertz and Herrmann 2000). Human gonadal dysgeneses serve as invaluable in vivo models for
study of gonadal development, since murine models may not accurately reflect the physiological
situation (Swain and Lovell-Badge 1999, Morrish and Sinclair 2002, Parker and Schimmer 2002).
Despite sex differences, gonadal development also provides an excellent model for study of
organogenesis and its genetic control.
Figure 4. Molecular events in mammalian sex determination and testicular differentiation
involving genes. Solid lines indicate activating effects, and dotted line, inhibition.
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5.3 Diseases of the Human Testis
Abnormalities of testicular function comprise a heterologous group of disorders that cause different
consequences depending on the phase of sexual development in which they are manifested.
Defects range from rare syndromes with underandrogenization to normal virilization with reduced
fertility. Tumors of the testis are the second most common malignancy, after leukemia, in men
between age 20 and 35. The epidemiological evidence suggests that testicular cancer, undescendent
testis, and impaired spermatogenesis are biologically closely associated (Skakkebaek et al. 1998).
5.3.1 Hypogonadism
Male hypogonadism refers to a failure in testicular function that eventually may lead to infertility
(Table 2). The most common developmental defect of the testis is Klinefelter’s syndrome, 47XXY
(Berkovitz and Seeherunvong 1998). Klinefelter males have typically divergent testicular histology
and small testes, and as a result, reduced testosterone production. In hypogonadotropic
hypogonadism such as Kallman’s syndrome (Hardelin 2001), testosterone production is reduced
due to a lack of stimulatory hormones. In patients with androgen resistance, the impact of androgens
is reduced. Complete androgen resistance results in XY male-to-female sex-reversal, whereas the
mildest forms of androgen resistance may result in infertility with otherwise normal genitalia
(Sultan et al. 2002). In cryptorchidism, one or both testes have failed to descend. Spermatogenesis
requires the lower temperature that is present in the scrotum, but the temperature-dependent
mechanism is unknown. Varicocele, cryptorchidism, and Klinefelter’s syndrome account for 45%
of known conditions in men with infertility (Greenberg et al. 1978, Griffin and Wilson 1998)
Table 2. Abnormalities of testicular function. (Modified from Griffin and Wilson 1998, Huhtaniemi and
Dunkel 2000).
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5.3.2 Tumors
Germ cell tumors, the most common type of testicular tumors (Table 3), are presumed to be derived
from primordial germ cells. Besides testis, germ cell tumors can originate in extragonadal sites
such as the mediastinum and brain. Stromal tumors, e.g., Sertoli and Leydig cell tumors, account
for the minority of testicular tumors (Kaplan et al. 1986). Germ cell and stromal tumors may be
hormonally active and cause endocrinological symptoms including gynecomastia and azoospermia.
Table 3. Classification of testicular tumors. (Table modified from Griffin and Wilson 1998; data from
Mostofi 1980).
5.4 The Gata Family of Transcription Factors
Transcription factors are trans-acting molecules that bind to specific cis-acting DNA sequences
on promoters and/or enhancers of genes (Lewin 1997, Berg et al. 2002). The members of the GATA
family of transcription factors form a group of these regulatory proteins which control gene
expression in multiple tissues. GATA transcription factors are related by their homologous DNA-
binding domains. GATA factors are well conserved through evolution; they are found in various
organisms ranging from cellular slime mold to humans. Even some plants are proposed to have
GATA homologs (Lowry and Atchley 2000). Vertebrate GATA factors descend from a common
ancestral sequence, whereas the evolutionary pathway among nonvertebrate GATA factors is
much different from that within vertebrates (Lowry and Atchley 2000).
All GATA factors contain one or two DNA-binding zinc finger domains of the distinctive form
Cys-X2-Cys-X17-18-Cys-X2-Cys (X represents any amino acid, and the subscript denotes their
number). These recognize a consensus DNA sequence, (A/T)GATA(A/G), known as GATA motif
(Ko and Engel 1993, Merika and Orkin 1993), which is an essential cis-element present in the
promoters and enhancers of a variety of genes (Orkin 1992).
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The function of GATA factors is modulated by their interaction with other transcription factors,
transcriptional co-activators, and co-repressors, the best-characterized group of cofactors being
the FOG proteins FOG-1 and FOG-2 that exist in species from flies to human. GATA and FOG
proteins not only share evolutionary conserved expression and structural homology but also
fulfill functionally conserved functions (Cantor and Orkin 2001, Fossett and Schulz 2001, Fossett
et al. 2001).
5.4.1 Mode of action
All GATA proteins are approximately 50 kDa in size. Vertebrate GATA proteins contain two highly
conserved zinc fingers and the N-terminal transcriptional activation domain. The zinc fingers in
particular are shown to play essential roles in GATA-mediated gene activation. The C-terminal
zinc finger is needed for DNA binding, and the N-terminal finger stabilizes this interaction and
mediates interactions with other factors such as FOG proteins (Martin and Orkin 1990, Trainor et
al. 1996, Tsang et al. 1997, Svensson et al. 1999, Tevosian et al. 1999). Within the zinc finger
regions, the amino acid sequence is almost identical between the divergent GATA factors. The
DNA binding region of mouse GATA-4 is 70% identical with that of mouse GATA-1, and mouse
and human GATA-4 zinc fingers are 100% identical (Huang et al. 1995).
All the GATA factors bind to GATA or GATA-like sequences. However, subtle differences exist in
their individual binding affinities for various promoters. Those differences and interactions with
other factors such as FOGs may allow precise programming of GATA function despite their
overlapping expression pattern in multiple tissues (Ko and Engel 1993, Merika and Orkin 1993,
Yamagata et al. 1995, Mackay et al. 1998, Sakai et al. 1998, Charron et al. 1999, Morrisey et al. 2000,
Kowalski et al. 2002).
GATA-1 is the founding member of GATA family and has received the most extensive study (Tsai
et al. 1989). Given that all GATA factors share structural homology, predictions as to the properties
and function of any GATA factor can be made to some extent based on the studies performed on
GATA-1. Indeed, results from studies in diverse developmental contexts with GATA factors other
than GATA-1 suggest that all GATA factors function in a quite similar manner.
In vitro studies suggest that many properties of the GATA family of proteins are shared and
interchangeable. In mouse GATA-1-deficient embryonic stem (ES) cells, GATA-3, GATA-4, and
even chicken GATA-1 are able to compensate for the hematological GATA-1 defect (Blobel et al.
1995). In these cells, even chimeric molecules, in which both zinc fingers of mouse GATA-1 were
replaced with the zinc fingers of human GATA-3 or with the single finger of the fungal GATA
factor, display rescue activity. However, in vivo experiments have failed to demonstrate that
GATA factors are functionally equivalent. In mice deficient in GATA-1, transgenic expression of
GATA-2 or GATA-3 has rescued the embryonic lethal phenotype of the GATA-1 mutation, but
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adult transgenic mice developed anemia (Takahashi et al. 2000). Furthermore, the embryonal lethality
of most GATA knockout mice indicates that GATA factors do not share complete functional
redundancy in vivo (Table 4).
5.4.2 Vertebrate GATA factors
Vertebrates have six GATA transcription factors, designated GATA-1 to GATA-6 according to the
order in which they were identified (Evans and Felsenfeld 1989, Tsai et al. 1989, Yamamoto et al.
1990, Arceci et al. 1993, Laverriere et al. 1994, Morrisey et al. 1996, Morrisey et al. 1997).
The GATA proteins are divided into two subgroups based on their expression pattern. GATA-1,
GATA-2, and GATA-3 are expressed mainly in blood-forming cells and are essential for normal
hemopoiesis (Pevny et al. 1991, Tsai et al. 1994, Pandolfi et al. 1995, Fujiwara et al. 1996, Ting et al.
1996, Shivdasani et al. 1997, Vyas et al. 1999).
GATA-4, GATA-5, and GATA-6 are expressed in visceral and parietal endoderm, heart, lung, liver,
pancreas, adrenals, gonads, gut epithelium, smooth muscle cells, and some other tissues. Gene
disruption studies on mice have revealed that these proteins are important for ventral
morphogenesis, heart, genitourinary tract and endoderm formation, and lung maturation (Kuo et
al. 1997, Molkentin et al. 1997, Morrisey et al. 1998, Koutsourakis et al. 1999, Molkentin et al. 2000,
Liu et al. 2002b).
GATA-1
GATA-1 was originally identified in hematopoietic cell lineages (Martin et al. 1990, Romeo et al.
1990, Orkin 1992, Zon et al. 1993) and was found to be essential for erythroid and megakaryocytic
cell differentiation (Pevny et al. 1991, Fujiwara et al. 1996, Shivdasani et al. 1997, Vyas et al. 1999).
In addition to hematopoietic cells, GATA-1 is expressed in Sertoli cells of the testis (Ito et al. 1993,
Yomogida et al. 1994) (Table 5). GATA-1 gene transcription in Sertoli cells is directed by the testis-
specific promoter 8 kb upstream to that in erythroid cells. The five exons that encode GATA-1
protein are commonly used by testis and erythroid transcripts (Ito et al. 1993, Onodera et al. 1997a,
Onodera et al. 1997b).
Table 4. Homozygous null mutations of GATA factors.
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GATA-1 is expressed in postnatal Sertoli cells in a stage-dependent manner, and maturing germ
cells may negatively control its expression (Yomogida et al. 1994). Furthermore, FSH via cAMP
reduces GATA-1 expression in testicular cells (rat Sertoli cells and mouse Leydig tumor cell line
MA-10) (Zhang et al. 2002). In cell culture studies, GATA-1 transactivates a number of testicular
genes, including inhibin α- and β-B-subunits, MIS, StAR, and aromatase (Feng et al. 1998, Feng et
al. 2000, Robert et al. 2002). The physiological relevance of these findings remains unclear, since
GATA-1 knockout animals die in utero before proper testis development (Fujiwara et al. 1996).
GATA-2
GATA-2 is preferentially expressed in the hematopoietic cell lineages (Tsai et al. 1989, Orkin 1992).
It is indispensable for normal hematopoiesis, neurogenesis, and genitourinary development (Tsai
et al. 1994, Zhou et al. 1998, Nardelli et al. 1999). In mice, impaired GATA-2 expression disturbs
Wolffian and Müllerian duct development, but testes develop normally. In the fetal ovary, GATA-
2 is expressed in the germ cells between E11.5 and 15.5, as judged by digoxygenin in situ
hybridization (Siggers et al. 2002). No GATA-2 expression has been detected in the testis.
GATA-3
Disruption of the GATA-3 gene leads to embryonic lethality due to noradrenaline deficiency. It
also results in abnormalities of the nervous system and of kidney development, in aberrations in
fetal liver hematopoiesis and in block of T-cell differentiation (Pandolfi et al. 1995, Ting et al. 1996,
Lim et al. 2000). In humans, GATA-3 haplo-insufficiency causes the HDR syndrome that results in
hypoparathyroidism, deafness, and renal anomaly (Van Esch et al. 2000). GATA-3 is expressed in
the Wolffian duct and mesonephros, but no reports exist on gonadal expression (Labastie et al.
1995, Debacker et al. 1999). Interestingly, GATA-3 serves a role also in adipocyte differentiation
(Tong et al. 2000).
GATA-4
GATA-4 is found in a number of different tissues. During embryonal development, it is expressed
in the primitive (yolk sac) endoderm, heart, gut, liver, and gonads, and in adult heart, intestine, and
gonads (Arceci et al. 1993, Kelley et al. 1993, Heikinheimo et al. 1994, Laverriere et al. 1994, Huang
et al. 1995, White et al. 1995, Morrisey et al. 1996).
The role of GATA-4 in the heart is the most extensively studied. GATA-4-deficient mice die
embryonally between E7.0 and E10.5 because of severe folding abnormalities (Kuo et al. 1997,
Molkentin et al. 1997). GATA-4 is essential for heart development through combinatorial
interactions with other transcription factors (Nemer and Nemer 2001). It is also linked to
hypertrophy-associated gene expression (Molkentin 2000, Hautala et al. 2001, Marttila et al. 2001,
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Kerkela et al. 2002, Yanazume et al. 2002). GATA-4 is also required for proper differentiation of
gastric epithelium (Jacobsen et al. 2002).
Besides the heart, GATA-4 is essential for testicular development, possibly by regulating SRY
expression (Tevosian et al. 2002). GATA-4 activates several gonads-expressed genes that encode
steroidogenic enzymes (StAR, aromatase), hormones (MIS, inhibin alpha, inhibin/activin beta-B),
and transcription factor SF-1 (Viger et al. 1998, Ketola et al. 1999, Silverman et al. 1999, Tremblay
and Viger 1999, Feng et al. 2000, Watanabe et al. 2000, Tremblay et al. 2001, Tremblay and Viger
2001a, Tremblay et al. 2002). DAX-1 represses MIS transcription in Sertoli cells by disrupting
transcriptional synergism between GATA-4 and SF-1 (Tremblay and Viger 2001b). This synergism
may represent a mechanism for the regulation of SF-1-dependent genes in other target tissues
such as the pituitary and adrenals. SF-1, FOG-1, and FOG-2 modulate transcriptional activity of
GATA-4 through distinct mechanisms depending on the cellular context (Tremblay et al. 2001,
Robert et al. 2002, Anttonen et al. 2003).
GATA-5
GATA-5 is expressed in the developing heart, lung, gut, and gonadal ridge (Laverriere et al. 1994,
Morrisey et al. 1997). It shares high amino acid-level sequence identity with murine GATA-4 and
GATA-6, but not with other GATA factors. GATA-5 regulates specific cardiac and gastric genes
(Gao et al. 1998, Charron and Nemer 1999, Nemer and Nemer 2002). Female mice with  homozygous
deletions for GATA-5 exhibit pronounced genitourinary abnormalities that include vaginal and
uterine defects and hypospadias. Male mice are unaffected (Molkentin et al. 2000).
GATA-6
During the embryonal period, GATA-6 has been detected in the primitive streak, visceral endoderm,
heart, stomach, liver, gut, atrial smooth muscle cells, developing bronchi, and urogenital ridge. It
is expressed in adult heart, stomach, gut, lung, pancreas, and ovary (Laverriere et al. 1994, Jiang
and Evans 1996, Morrisey et al. 1996, Narita et al. 1996, Suzuki et al. 1996, Huggon et al. 1997).
Human GATA-6 is a 499-amino-acid protein almost identical in the two zinc finger-binding domains
with other human GATA proteins (Suzuki et al. 1996, Huggon et al. 1997).
GATA-6 is essential for visceral endoderm formation (Morrisey et al. 1998, Koutsourakis et al.
1999) and for proper lung development (Keijzer et al. 2001, Liu et al. 2002b, Yang et al. 2002). Based
on in vitro studies, GATA-6 regulates genes expressed in the heart, lung, and gut (Gao et al. 1998,
Charron et al. 1999, Liu et al. 2002a, Robert et al. 2002). In the gonads, GATA-6 has been proposed
to upregulate MIS, StAR, inhibin α, and aromatase genes, and its activity is down-regulated by
FOG-1 and FOG-2 (Robert et al. 2002). Due to early embryonic lethality before gonadal development,
the in vivo relevance of these findings remains unclear (Morrisey et al. 1998, Koutsourakis et al.
1999).
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5.4.3 Friends of GATA, FOG-1, and FOG-2
The transcriptional activities of GATA factors are modulated by their interactions with other
transcription factors and with transcriptional coactivators and repressors (Krause and Perkins
1997). FOG-1 is the multitype zinc finger protein first demonstrated to interact with GATA-1, and it
serves as a cofactor for GATA-1-mediated transcription (Tsang et al. 1997). It is coexpressed with
GATA-1 in the hematopoietic tissues and in adult liver and testis. FOG-1 itself and its interaction
with GATA-1 are essential for normal hematopoiesis (Tsang et al. 1998, Crispino et al. 1999,
Deconinck et al. 2000, Chang et al. 2002).
FOG-2 was originally described as a cofactor for GATA-4 (Holmes et al. 1999, Lu et al. 1999,
Svensson et al. 1999, Tevosian et al. 1999). It is a1151-amino acid nuclear protein that contains
eight zinc fingers structurally related to those of FOG-1. FOG-2 is predominantly expressed in
embryonal mouse heart, urogenital ridge, and neuroepithelium. In the adult, it is expressed in the
heart, brain, and testis. FOG-2 interacts with all known GATA factors, either activating or repressing
their transcriptional activity, depending on the promoter and cell type in which they are tested.
FOG-2 and its interaction with GATA-4 are essential for heart morphogenesis and testicular
development (Svensson et al. 2000, Tevosian et al. 2000, Crispino et al. 2001, Tevosian et al. 2002).
FOG-1 and FOG-2 function in hematopoiesis and during cardiogenesis are conserved in Drosophila,
Xenopus, and mammals (Cantor and Orkin 2001, Fossett and Schulz 2001, Fossett et al. 2001).
5.4.4 Clinical implications of GATA and FOG families
Human studies aid in evaluation of the relevance of in vivo and in vitro animal studies. When the
findings of these studies are combined, new therapeutic approaches may become possible. GATA
factors have been linked to the pathogenesis of various human diseases: A mutation in the
GATA-1 DNA-binding site in the platelet glycoprotein Ιbβ gene promoter results in a rare bleeding
disorder, Bernard-Soulier syndrome (Ludlow et al. 1996). Mutations in GATA-1 zinc fingers that
disturb DNA binding or interaction with FOG-1 may lead to anemia, trombocytopenia, and to
thalassemia (Nichols et al. 2000, Freson et al. 2001, Mehaffey et al. 2001, Yu et al. 2002). Mutations
Table 5. Expression of GATA factors in mouse gonads. ND = not defined.
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in GATA-1 may also constitute one step in the pathogenesis of the megakaryoblastic leukemia in
Down syndrome (Wechsler et al. 2002). GATA-3 has been proposed to play a role in asthmatic
airway inflammation (Nakamura et al. 1999, Ray and Cohn 1999, Christodoulopoulos et al. 2001).
GATA-4 may be involved in the pathogenesis of some yolk sac, adrenal, gastrointestinal, and
ovarian tumors (Kiiveri et al. 1999, Pehlivan et al. 1999, Siltanen et al. 1999, Laitinen et al. 2000, Lin
et al. 2000, Lassus et al. 2001). Furthermore, GATA-4 haploinsufficiency may contribute to congenital
heart disease in patients with monosomy of 8p23.1 (Pehlivan et al. 1999).
5.5 Role of Apoptosis in Testis
Apoptosis, also known as programmed cell death, is an evolutionarily conserved process that
plays an essential role in the regulation of tissue development and homeostasis. It is involved in
normal development and in the pathogenesis of diverse diseases (Jacobson et al. 1997, Raff 1998).
Apoptotic cells commit controlled suicide in order to remove structures or cells that are no longer
needed. In the testis, apoptosis serves a role in regulating the growth and survival of germ cells
which eventually results in normal spermatogenesis (Dunkel et al. 1997, Matsui 1998, Sinha Hikim
and Swerdloff 1999, Kierszenbaum and Tres 2001). Furthermore, regression of Müllerian ducts
occurs through apoptosis (Roberts et al. 1999). The Bcl-2 family of proteins is a major regulator of
germ cell apoptosis, either by supporting cell survival or promoting cell death (Figure 5). The
balance between germ cell survival and death is a prerequisite for spermatogenesis and testis
development. Bcl-2 and bax have well-established roles in those processes (Rodriguez et al. 1997,
Russell et al. 2002). Additionally, the balance and dimerization of pro- and anti-apoptotic factors
controls cell death and survival (Yang et al. 1995, Rucker et al. 2000, Yan et al. 2000b, Yan et al.
2000c).
Figure 5. Regulation of apoptosis by Bcl-2 family of proteins. Modified from (Sinha Hikim and Swerdloff
1999). Bcl-2 family members on the left promote cell-survival and on the right are pro-apoptotic.
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GATA factors are proposed to play roles in apoptotic processes. Best characterized is the effect of
GATA-1 on the production of red blood cells (De Maria et al. 1999, Orkin and Weiss 1999).
Caspases, which are death-promoting enzymes, inactivate GATA-1, which results in apoptotic
death of maturing red blood cells. In the ovary, from fetal until adult life GATA-4 may protect
granulosa cells from apoptosis (Heikinheimo et al. 1997, Vaskivuo et al. 2001). In embryonic stem
cells, cardioblast differentiation is blocked and cells are lost through apoptosis in the absence of
GATA-4 (Grepin et al. 1997). GATA-6 downregulation leads to apoptosis within the embryonic
endoderm and in colorectal cancer cells (Morrisey et al. 1998, Shureiqi et al. 2002). No reports have
appeared concerning GATA factors and their possible role in apoptosis of the testis.
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Aims of the Study
6 AIMS OF THE STUDY
The aims of the study were to study:
1) Temporal and spatial cell-specific expression patterns of transcription factors GATA-1,
GATA-4, GATA-6 and their co-factors FOG-1 and FOG-2 during testicular development from
the fetal period to adulthood.
2) Regulation of GATA-4 and GATA-6 in testis by both in vitro and in vivo approaches.
3) Gonadal genes that are regulated by testicular GATA factors.
4) Role of gonadal GATA factors in human testicular diseases.
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7 SAMPLES AND METHODS
These studies were accepted by the Ethics Committees of the Children’s Hospital of the University
of Helsinki and the University of Oulu, and conducted according to recommendations of the
Declaration of Helsinki. Animal studies were conducted in accordance with the NIH Guide for the
Care and Use of Laboratory Animals.
Table 6. Samples and methods of the studies.
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7.1 Tissue samples
7.1.1 Human testicular samples
Fetal and premature newborn testicular tissue samples (n = 16) at weeks 12 to 40 came from
abortions induced for socio-medical reasons and from autopsy specimens. Normal juvenile (n = 9)
or pubertal (n = 1) testis biopsy samples were obtained from boys diagnosed with acute
lymphoblastic leukemia (ALL) without testicular involvement. Testis samples from cryptorchid
boys (n = 33) were obtained from diagnostic biopsies during orchidopexy before (n = 19) or after
(n = 14) hCG treatment. Undescended testes were classified as either inguinal or high scrotal.
Testicular tissue from patients with androgen resistance (n = 11) came from therapeutic
gonadectomies. Testis samples also came from prostate cancer patients having received GnRH-
agonist (n = 2) or GnRH-agonist-antiandrogen (n = 1) treatment before orchidectomy. One biopsy
sample was obtained from a 26-year-old man with Kallman’s syndrome who had received human
menopausal gonadotropin (HMG) treatment for 2.5 years. Testicular samples from adult patients
with prostate cancer (n = 7) served as controls. Sertoli (n = 1), Leydig (n = 5), and germ cell tumors
(n = 6) came from patients undergoing gonadectomy.
7.1.2 Animal samples, models, and cell culture
Samples from mouse embryos, and fetal and postnatal testes were obtained by mating B6SJLF1/J,
CBA, or NMRI mice. For estimating embryonal age, the noon of the day on which the copulating
plug was found was considered embryonal day 0.5. Precise staging of dissected embryos was
performed according to The Atlas of Mouse Development. PCR analysis of the Zfy or SRY gene
was conducted in order to determine the sex of E10.5 and E12.5 embryos. To study hormonal
effects, testicular tissue was harvested from a hypogonadal (hpg) mouse strain, 3-week-old Sprague-
Dawley rats treated with gonadotropin-releasing hormone (GnRH) receptor antagonist azaline B,
and 3-month old Sprague-Dawley rats after treatment with ethane-1,2-dimethane sulphonate (EDS).
Immortalized Leydig cell tumor lines BLT-1 and mLTC-1 were cultured in plastic dishes on Dulbecco’s
Modified Essential Media (DMEM) with GlutaMAX®/F12 1:1 buffered with HEPES (20 mmol/L)
and supplemented with 10% heat-inactivated fetal bovine serum, glucose (4.5 g/L), and gentamicin
(100 mg/L). Cells were used for immunohistochemistry after 2 to 3 days in culture. For hormone
stimulation, cells were cultured for 24 h in the presence of 1, 10, and 100 µg/L recombinant hCG, 10
µg/L progesterone, 20 µg/L aminoglutethimide (AMG), or a combination of 100 µg/L recombinant
hCG and 20 µg/L aminoglutethimide (AMG).
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7.2 Experimental methods
7.2.1 RNase protection assay
RNase protection assays were performed with a commercially available kit according to
manufacturer’s recommendations (Ambion), with 10 µg of total testicular RNA. The antisense
riboprobes: GATA-4, GATA-6, and ß-actin, were 32P-labeled.
7.2.2 Northern hybridization
Total RNA was isolated with the Qiagen RNeasy Mini Kit or the guanidinium thiocyanate method.
Denatured total RNA (10or 20 µg) was subjected to electrophoresis on a 1%, 1.2%, or 1.5%
denaturing agarose gel and then transferred onto nylon membranes. These membranes were
hybridized with 32P-labeled RNA probes for mouse GATA-4 and GATA-6 or with synthetic
oligonucleotide probes for human GATA-4. For increasing sensitivity of the hybridization for
human GATA-4, the two different oligomers were labeled simultaneously and pooled for
hybridization. Hybridization was performed at 60°C overnight, and the membranes were washed
three times for 20 min each at 60°C with 1x SSC/0.1 % SDS. Hybridization signals were detected by
autoradiography or by phosphoimager.  Intensities of the specific bands were quantified with
Tina® software and normalized to 28S and to 18S ribosomal RNAs in the gel stained with ethidium
bromide. A specific probe for ribosomal 28S mRNA also served as a loading control.
7.2.3 mRNA in situ hybridization
Tissue samples were washed in PBS and then fixed in 4% paraformaldehyde or formalin and
embedded in paraffin, or they were frozen in liquid nitrogen in cryopreservation solution. In situ
hybridization was carried out with minor modifications as described elsewhere (Wilkinson 1992).
In brief, tissue sections (8-10 µm) were deparaffinised, permeabilized, dehydrated, and then
incubated with 1 x 106 cpm of 33P-labeled antisense or sense riboprobes in a total volume of 80 µl
and incubated overnight at temperatures of 60 to 62°C. Hybridization signals were detected after
a 5- to 21-day exposure to emulsion at 4°C.
7.2.4 Western blotting
Tissue sections were homogenized on ice in homogenization buffer. After centrifugation at 17 000
g at 4°C for 30 min, the supernatants were collected and their protein concentrations were
determined by Bio-Rad DC protein assay. Proteins (40 µg) were loaded onto 10% SDS-
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polyacrylamide gel, and electrophoresis was performed at 160 V. The proteins were transferred
onto polyvinylidene difluoride (PVDF) membranes by electrophoresis for 2 h at 4°C in transfer
buffer at 100 V. The transfer was checked by staining with 0.2% Ponceau S in 3% trichloroacetic
acid. GATA-4 protein on the membrane was detected by an affinity-purified rabbit polyclonal
antibody to GATA-4 at dilution 1:1000, followed by horseradish peroxidase-conjugated secondary
antibody. The bound secondary antibody was located with the ECL detection kit.
7.2.5 Immunohistochemistry
Testicular samples or cultured Sertoli and Leydig cells were fixed in 4% paraformaldehyde, formalin,
or Stieve’s fixative and embedded in paraffin, or they were frozen in liquid nitrogen in
cryopreservation solution. Tissue sections (6-8 µm) were deparaffinized in xylene and hydrated
gradually through graded alcohols. If needed, endogenous peroxidase activity was blocked with
3% hydrogen peroxide in methanol. Samples were subjected to immunohistochemistry by the
antibodies described in Table 7. Antibodies were at 1:25-1:500 dilution. Samples with primary
antibody were incubated at 37°C for 1h or at 4°C overnight. An avidin-biotin immunoperoxidase
system served to visualize bound antibody; 3-amino-9-ethylcarbazole or 3,3’-diaminobenzedine
(DAP) served as the chromogen, and the development reaction occurred in the presence of 0.03%
H202. Samples were analyzed by light/darkfield and phase-contrast microscopy. Whenever possible,
in immunohistochemistry and in situ hybridization, the expression patterns for respective antibodies
and transcripts were studied for adjacent tissue sections.
Table 7. Antibodies
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7.2.6 In situ DNA 3'-end labeling
Apoptosis was qualitatively identified in the testes by use of an in situ DNA 3'-end labeling
(TUNEL) kit (Oncor). Paraffin sections of testes were rehydrated through an alcohol series, and
permeabilized in proteinase K, and endogenous peroxidase activity was inhibited by 5% hydrogen
peroxide. DNA fragmentation was identified by applying terminal transferase enzyme with
digoxigenin-labeled nucleotides to the samples and incubating for 1 h under coverslips.
Antidigoxigenin antibody served to recognize the digoxigenin-labeled nucleotide chains attached
to the 3'-ends of sample DNA. A color reaction was produced with 3,3’-diaminobenzedine in the
presence of 0.03% hydrogen peroxide.
7.2.7 Transfections
Leydig tumor cell line mLTC-1 and granulosa cell line KK-1 were split at a density of 1 x 105 the day
prior to transfection and then transfected with DOTAP Liposomal Transfection Reagent
(Boehringer) with a slight variation from manufacturer’s instructions. The 211-bp fragment of
inhibin α was cloned into the reporter plasmid pTKGH (Nichols Institute Diagnostics). The first,
second, or first and second GATA sites in the inhibin α promoter were mutated by replacing the G
with a C, by site-directed mutagenesis with the Gene Editor Site Directed Mutagenesis System
(Promega). For each well, the appropriate pTKGH reporter plasmid was mixed with the expression
vector pMT2-GATA-4 or with the control vector pMT2. The DNA was then diluted with 20 mM
Hepes buffer and added to the DOTAP, and the transfections were carried out according to
manufacturer’s instructions; cells were incubated in total 72 h. Aliquots were removed for use in
the hGH radioimmunoassay (Nichols Institute Diagnostics). All transfections were carried out in
triplicate and repeated at least 3 times.
7.2.8 Statistics
Statistical analyses were performed on the basis of 3 independent experiments. Data were subjected
to one-way analysis of variance and by the SuperANOVA program, followed by Duncan’s New
Multiple Range and Fisher’s Protected LSD post-hoc tests. All p-values less than 0.05 were
considered significant.
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8 RESULTS AND DISCUSSION
8.1 Expression of GATA and FOG factors during testicular
development
It is of utmost importance to know the temporal and spatial expression pattern of a given gene in
order to understand its function. In vitro gene activation studies are invaluable tools to explore
gene function. These studies lack, however, the normal cell context and composition, and this may
result in misjudgments. Detailed in vivo studies of gene expression are needed to reconcile
discrepancies with cell culture models, thus defining the interactions that actually may occur and
regulate gene expression in any given tissue.
Previous studies indicate that GATA-1, GATA-4, and GATA-6 are expressed in the gonads (Arceci
et al. 1993, Yomogida et al. 1994, Narita et al. 1996, Suzuki et al. 1996), but their testicular expression
patterns have not been studied in detail. Findings show expression of GATA-1 outside the
hematopoietic system to be restricted to the Sertoli cells of the testis, and GATA-4 and GATA-6 to
be present in the ovary and testis. In the ovary, GATA-4 and GATA-6 have been expressed in a
distinct, but partially overlapping manner (Heikinheimo et al. 1997). GATA-1 already had a well-
established role in the regulation of hematopoiesis (Pevny et al. 1991), and GATA-4 and GATA-6
were proposed to regulate heart differentiation and function (Heikinheimo et al. 1994, Ip et al. 1994,
Molkentin et al. 1994, Thuerauf et al. 1994, Morrisey et al. 1996). Taken that GATA-1, GATA-4, and
GATA-6 are expressed in the gonads and that they are potent regulators of gene expression in
various tissues, they could well be important regulators of testicular function.
8.1.1 Expression in urogenital ridge and fetal testis (I-IV)
Expression of GATA-1 during the earliest stages of testicular development was then unresolved,
as was the cell-specific expression of GATA-4 and GATA-6 in the testis. When FOG-1 and FOG-2
were discovered, their cell-specific expression as to the gonads was not yet addressed (Tsang et
al. 1997, Svensson et al. 1999, Tevosian et al. 1999). Therefore, in this thesis, the temporal and
spatial expression of GATA-1, GATA-4, and GATA-6 in the testis, as well as that of their cofactors
FOG-1 and FOG-2 from the early embryonic period to adulthood is explored in detail.
GATA-1 and FOG-1 were absent from the undifferentiated genital ridge of the male mouse, as
studied by immunohistochemistry (III) (Figure 6 and Table 8). With further fetal testicular
development, GATA-1 remained undetectable throughout embryogenesis, whereas FOG-1 protein
was evident in the Sertoli cells after testicular differentiation at E15.5, and this expression persisted
until term. GATA-4 and FOG-2 mRNAs and proteins were detected in the urogenital ridge of E10.5
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male embryos (III). GATA-4 expression was obvious throughout fetal testicular development, and
localized in the Sertoli, Leydig, and myoid cells as well as cells of the tunica albuginea (I, III).
Conversely, the expression of FOG-2 mRNA and protein diminished in Sertoli cells, parallel to
advancing fetal testicular development. Some interstitial cells and cells in the tunica albuginea,
however, expressed FOG-2 mRNA and protein also in late fetal testis (II).  As judged by mRNA in
situ hybridization, GATA-6 transcripts were detected at E13.5 in the testicular cords, and their
expression persisted there throughout fetal development (I).
The resolution of in situ hybridization did not allow us to determine the precise cell types expressing
GATA-6 within the cords (I). Because GATA-6 antibodies were unavailable at that time, we were
unable to assess whether GATA-6 protein was present in Sertoli or germ cells. Later, we conducted
GATA-6 immunohistochemistry on fetal testis samples. In contrast to the findings in man, GATA-
6 protein was localized in testis cords and seminiferous tubules in the germ cells, and not in Sertoli
cells (unpublished results).
In human fetal testis, GATA-4 and GATA-6 mRNAs and proteins were present between gestational
weeks 12 and 40 (II, IV). Sertoli and Leydig cells expressed both GATA-4 and GATA-6, but myoid
cells were positive only for GATA-4. A subset of the Sertoli and Leydig cells did not express
GATA-6. Immunoreactivity for GATA-4 and GATA-6 was most intensive at the beginning of the
second trimester and declined towards term. Gonocytes were negative for both these factors at all
ages studied (II, IV).
Expression of GATA-4 overlapped in human fetal testis with that observed in the mouse. In
contrast, the expression of GATA-6 protein in testicular cords differed between man and mouse
(IV; our unpublished results). In a recent study, GATA-6 expression was detected in mouse fetal
Sertoli cells by digoxygenin in situ hybridization (Robert et al. 2002). Unfortunately, the data
presented was inadequate to clarify the cell types that expressed GATA-6. The reason for these
contradictory results for GATA-6 Sertoli and germ cell expression remains unclear. It may reflect
differences between mouse strains or methods, but further efforts should be made to clarify the
expression of GATA-6 in mouse testis. Of interest to note, GATA-6 mRNA has already been
detected in the undifferentiated genital ridge (Morrisey et al. 1996). Thus, GATA-6 may play a role
in the regulation of gonadal development.
Table 8. Expression of GATA and FOG factors during mouse testicular development.
ND = not defined.
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8.1.2 Fetal expression of GATA and FOG factors in relation to gonadal
developmental genes
GATA-4 and FOG- 2 are co-expressed in the genital ridge before testicular cords have formed, and
their expression overlaps with that of several key regulators of gonadal development and sexual
differentiation. GATA-4 and FOG-2 are expressed simultaneously with WT-1 and SF-1 in the
urogenital ridge and just previous to expression of SRY, SOX-9, MIS, and DAX-1 (Swain and
Lovell-Badge 1999, Capel 2000, Morrish and Sinclair 2002). Given that all those factors have a
crucial impact on testicular development, the expression patterns of GATA-4 and FOG-2 strongly
indicate roles for them in early testicular development. Furthermore, GATA-4 RNA and protein are
expressed in cells of the coelomic epithelium of the primitive streak embryo at E7.0 (Heikinheimo et
al. 1994). Some of these cells will eventually give rise to the testis Sertoli cells, and expression of
GATA-4 may be needed for initiating and/or maintaining the differentiation pathway towards a
mature Sertoli cell. If this is the case, GATA-4 is one of the earliest Sertoli cell markers.
FOG-1 was originally identified as a cofactor for GATA-1 (Tsang et al. 1997). In the fetal testis,
FOG-1 is expressed at E15.5, co-localizing with GATA-4 in Sertoli cells. Given that GATA-1 is not
expressed in fetal testis, it is plausible that in fetal testis, FOG-1 interacts not with GATA-1, but
rather with GATA-4. Indeed, recent studies have shown that FOG-1 and FOG-2 are capable of
interacting with known testicular GATA factors (Robert et al. 2002). In fetal testis, FOG-2 expression
gradually ceases, but it is abundantly expressed throughout the fetal period in the ovary (III)
(Anttonen et al. 2003).  This sexually dimorphic expression pattern after gonadal differentiation
may indicate that after the very early phases of testicular differentiation, FOG-2 promotes female
rather than male development.
Figure 6. Schematic illustration of GATA-4, GATA-6, FOG-1, and FOG-2 expression in mouse
genital ridge and fetal testis.
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8.1.3 Expression in postnatal testis (I-III)
Newborn testes are functionally immature organs. In mammals, the period before puberty or sexual
maturity ranges from weeks to several years. In mice, testicular development starts shortly after
birth, and the last phases of the neonatal period overlap with the beginning of puberty. In human
males, however, the period before the onset of puberty ranges from 9 to 13 years (Chemes 2001).
Nevertheless, during that time, considerable changes in testicular morphology occur. The testis
increases in size as Sertoli cells proliferate, Leydig cells mature to adult-type steroid-producing
cells, and finally spermatogenesis begins, ultimately to produce fertile spermatozoa. Given that
these GATA and FOG transcription factors are likely to play important roles in fetal testicular
development, they may be the regulators of postnatal development and function, as well. In order
to reveal the temporal and spatial expression patterns of these factors in the postnatal testis, we
conducted mRNA in situ hybridization and immunohistochemical analyses of testicular samples
from newborn to adult testis (I-IV).
GATA-4 and GATA-6 transcripts were detectable in the testis of the newborn mouse, and this
expression persisted throughout adulthood (I) (Figure 7 and Table 8). The expression of GATA-4
protein localized to Sertoli and Leydig cells without any stage-specificity. Diverging from the
GATA-4 expression pattern, GATA-6 was expressed in spermatogonia and Leydig cells, as seen
by immunohistochemistry (unpublished results). In prepubertal human testes, GATA-4 protein
was expressed in Sertoli cells and spermatogonia, whereas only a few Leydig cells were faintly
GATA-4 positive. After puberty, GATA-4 was expressed in the Sertoli cells, was upregulated in the
Leydig cells, and downregulated in the germ cells (II).
FOG-1 protein was detectable in the Sertoli cells of the newborn mouse, and the expression
persisted there throughout postnatal testicular development (III). From P7 onwards, FOG-1
expression was similar to that of GATA-1. In the adult testis, Sertoli cell expression of FOG-1 and
GATA-1 was stage-specific; these were predominantly expressed in the Sertoli cells of stage VII to
XII seminiferous tubules (III).
FOG-2 mRNA and protein were abundantly expressed in the testis of the newborn mouse. They
were present in the Sertoli and Leydig cells, and in the cells of the tunica albuginea. Some of the
gonocytes were also immunoreactive for FOG-2, but this was never noted after the first postnatal
week. Along with advancing spermatogenesis, FOG-2 expression in the somatic cells ceased,
whereas it was upregulated in germ cells. In adult testis, midpachytene spermatocytes up to step
9 spermatids were positive for FOG-2 predominantly in stage VII to XII seminiferous tubules (III).
Comparison of the expression patterns of GATA-1 and MIS reveals an inverse relationship in their
Sertoli cells expression, suggesting that GATA-1 may downregulate MIS in male mice during the
establishment of puberty (Beau et al. 2000). At that time, GATA-1 co-localized with FOG-1 in their
Sertoli cells, and the expression was stage-specific later in adult testis.  This indicates that
Results and Discussion
41
FOG-1 may act as a co-activator or co-repressor for GATA-1. In the adult testis, Sertoli cell
expression of inhibin α and inhibin βB-subunits (Kaipia et al. 1992, Majdic et al. 1997), FSH
receptor (FSHR) (Heckert and Griswold 1991, Heckert and Griswold 1993), stem cell factor (SCF)
(Hakovirta et al. 1999), and androgen receptor (AR) (Bremner et al. 1994, Zhou et al. 2002) is stage-
specific (Table 9). The stage-specificity of these gene products suggests that they may be target
genes for those GATA/FOG family members. Of note, GATA-4 expression is not stage-specific (I-
III). Nevetherless, GATA-4 activates and binds to promoters of genes of stage-specific expression.
Stage-specific expression of GATA/FOG protein may thus not be an ultimate requirement for the
activation of a given gene.
A profound change occurs in the expression of FOG-2 parallel to advancing spermatogenesis,
namely, somatic cells cease to express FOG-2, and in the adult testis, it is expressed stage-specifically
in spermatocytes and spermatids. FOG-2 and GATA-6 are the only GATA and FOG family members
expressed in both male germ and somatic cell lineages. Tyrosine-kinase receptors, namely c-kit
and its truncated form tr-kit, are also expressed in germ cells (Manova et al. 1990, Manova and
Bachvarova 1991) and in Leydig cells. The c-kit receptor and its ligand SCF are essential for
maintenance of PGCs, and postnatally they regulate spermatogenesis and Leydig cell development
(Mauduit et al. 1999, Rossi et al. 2000, Yan et al. 2000a, Kierszenbaum and Tres 2001). Because c-
kit receptors have essential GATA-binding sites in their promoters (Rossi et al. 1992, Yamamoto et
al. 1993), an intriguing possibility is that GATA-6 and FOG-2 may act in concert with c-kit and its
derivatives within the germ and Leydig cells.
Figure 7. Schematic illustration of GATA-1, GATA-4, GATA-6, FOG-1, and FOG-1 expression in
mouse testis.
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In prepubertal human testis, GATA-4 was expressed in spermatogonia (II). This was the only
period of testicular development at which GATA-4 expression was detectable in germ cells. During
the first months of postnatal life, fetal gonocytes resume their mitotic activity and differentiate
into spermatogonia (de Rooij 2001). After this initial differentiation, there appear incomplete
spermatogenic waves before the onset of puberty (Chemes 2001). The expression of GATA-4 in a
subset of spermatogonia may relate to this premature germ cell differentiation/proliferation. The
same expression pattern was not observed in the mouse testis. However, in another study, GATA-
4 expression was detected in the germ cells of the adult mouse, not in Sertoli or Leydig cells (Viger
et al. 1998). It is therefore possible that some minor species and strain-specific differences exist in
the expression patterns of GATA and FOG proteins. The reason for and significance of these
differences remain unclear.
In human testis, a few prepubertal Leydig cells showed weak GATA-4 expression, whereas robust
GATA-4 expression was detected after puberty. The precursors of adult type Leydig cells are
hormonally inactive before puberty (Chemes 2001). At the initial stages of puberty, Leydig cell
precursors activate and differentiate into steroid-producing cells. This testosterone production
Table 9. Genes with stage-specific expression in Sertoli cells.
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coincides with increasing GATA-4 expression, suggesting a possible link between GATA-4 and
androgen production. This is supported by findings in fetal testes, as well. GATA-4 expression is
at its highest in Leydig cells when they are hormonally most active, just before midgestation
(Tapanainen et al. 1981). Furthermore, results from in vitro gene activation studies indicate that
GATA-4 activates genes essential for steroidogenesis (section 8.3.4).
Figure 8. Mouse FSH receptor promoter
binding GATA-4 protein. EMSA performed
with 32P-labeled double-stranded FSHR
oligonucleotide corresponding to nucleotides
–543/-528. This promoter sequence of FSHR
includes a putative GATA binding site just
upstream of the second major transcription
initiation site. Arrow on the left indicates the
complex formed by 32P-labeled FSHR probe
and GATA-4 protein from a mouse Sertoli cell
tumor line (MSCFSHR-1) nuclear extract (10
µg). GATA-4, but not GATA-1, antibody
bound to FSHR/GATA-4 complex (GATA-4
super shift). When the first G was mutated to
C at the GATA site, no FSHR/GATA-4
complex was formed (mutated FSHR). A cold
competitor was used in 0.1, 1, 10, and 50-fold
excess (triangle) and 50-fold excess in cold
mutated FSHR; goat normal serum served as
PI control for GATA-4.
8.2 Regulation of testicular GATA factors
8.2.1 Cell culture (I)
It has been demonstrated that FSH treatment of the mouse Sertoli cell line MSC-1 results in a
modest increase in the steady state level of GATA-4 mRNA but not that of GATA-6 (Heikinheimo
et al. 1997). Given these findings, we used Northern hybridization in order to study the regulation
of GATA-4 in Leydig cell lines in which it was abundantly expressed (I). In two Leydig cell tumor
lines, mLTC-1 and BLT-1, hCG stimulation (100 µg/L) resulted in a modest but significant
upregulation of GATA-4 mRNA expression, whereas progesterone (10 µg/L) significantly
downregulated GATA-4 mRNA levels. After blocking steroidogenesis with aminoglutethimide (20
µg/L), no significant alteration in GATA-4 mRNA levels was observable (I). No GATA-6 mRNA
expression could be detected in these cells before or after hormonal treatments (I).
In summary, stimulation with gonadotropins resulted in modest changes in the steady state levels
of GATA-4 mRNA in gonadal cell lines (I) (Heikinheimo et al. 1997). These results indicate that
gonadotropins may upregulate GATA-4 expression in Sertoli and Leydig cells, i.e., in the cells
expressing receptors for these pituitary gonadotropins in the testis (Griffin and Wilson 1998). Our
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findings thus indicate that GATA-4 may be involved in the gonadotropin-induced signaling
cascade leading to cAMP-activated gene expression.
Not only GATA-4 but also GATA-1 may be regulated by gonadotropins. In the primary cultures of
rat Sertoli cells, FSH suppressed GATA-1 mRNA but not that of GATA-4 (Zhang et al. 2002). The
same effect on GATA-1 was also seen with cAMP in the MA-10 Leydig cell line, indicating that
gonadotropin regulation of GATA factors may occur through the cAMP pathway. Although some
results on GATA-4 regulation are controversial, testicular GATA factors seem to be differentially
regulated by gonadotropins. Cell lines used in in vitro studies may exhibit different settings or
variable amounts of other proteins that further modulate the impact of hormones on GATA
expression. Furthermore, tumor cell lines and purified primary cell cultures lack the normal signaling
control from the adjacent tissues, and this may also contribute to somewhat controversial results.
8.2.2 Regulation of GATA-4 and GATA-6 in vivo (I)
In order to gain insight into the hormonal regulation of GATA-4 and GATA-6 in vivo, we used
several models of genetically or pharmacologically manipulated animals. The hormonal regulation
of these factors was studied by disrupting the hypothalamic-pituitary-gonadal axis at various
sites: hpg mice (Cattanach et al. 1977) exhibit congenital and functionally complete gonadotropin
deficiency; azaline B treatment (Campen et al. 1995) results in postnatal gonanadotropin deficiency,
and EDS treatment (Bartlett et al. 1986) destroys Leydig cells, leading to testosterone depletion
with subsequent Sertoli cell dysfunction (Table 10).
Table 10. Murine models in Study (I).
GATA-4 expression in animal models was studied by in situ mRNA hybridization and
immunohistochemistry, and GATA-6 expression by in situ mRNA hybridization (I). Congenital
lack of gonadotropins or the treatment applied did not totally abolish GATA-4 expression in the
seminiferous tubules or interstitium. GATA-4 expression persisted in Sertoli and Leydig cells of
hpg mice, and in Sertoli cells of azaline B-treated rats. EDS treatment did not affect GATA-4
expression in Sertoli cells. However, the expression intensity of GATA-4 in the testes of hpg mice
was reduced, indicating downregulation of GATA-4 expression by the total absence of
gonadotropins. On the contrary, no detectable changes appeared in GATA-6 expression in hpg
mice or after chemical treatment of azaline B- and EDS-treated rats.
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Human studies on GATA-4 expression offered the possibility to assess indirectly the in vivo
regulation of GATA-4 (II). Results of those studies were in line with results in animal models. In
fetal Sertoli cells, that strongest GATA-4 expression coincided with high serum FSH levels (Kaplan
et al. 1976) suggests that GATA-4 may be under gonadotropic control also in human beings.
GATA-4 was in low or absent from Sertoli and Leydig cells of patients with androgen resistance,
suggesting that congenital lack of androgen action influences GATA-4 expression. Furthermore,
after hormonal treatment for prostate cancer, GATA-4 expression remained unchanged in Sertoli
cells (GnRH agonist and GnRH agonist plus antiandrogen). These results agree with findings in
rodent testes after GnRH receptor antagonist treatment or chemical abolition of Leydig cells.
In the light of current findings, the normal testicular response to gonadotropins and androgen
action are both needed for normal GATA-4 expression. However, neither gonadotropin nor androgen
action nor both are prerequisites for basal expression of GATA-4 and GATA-6. Gonadotropin
stimulus may be more important for GATA-4 expression during fetal development than postnatally,
taken that changes in the expression of GATA-4 were seen only in congenital gonadotropin- and
androgen defects. Furthermore, it is most likely that not only gonadotropins and androgens, but
other hormones and factors are also involved in the regulation of GATA-4. For example, progesterone
downregulated GATA-4 expression in Leydig cell tumor lines (I). Alternatively, GATA-4 may well
be constitutively expressed in testis somatic cells, making the response to hormonal stimulus
modest. The effects of hormonal stimuli on GATA-4 expression possibly are mediated indirectly
through cofactors which are hormonally inducible (Silverman et al. 1999). Because in situ
hybridization and immunohistochemistry are insufficiently sensitive to detect minor changes in
RNA and protein expression, and methods like real-time RT-PCR should be applied to enhance
sensitivity.
In the ovary, GATA factors are probably under more stringent hormonal control than in the testis.
This suggestion is based on in vivo studies in which pregnant mare’s serum gonadotropin
(PMSG) and estrogen enhanced follicular expression of GATA-4 and GATA-6; induction of ovulation
with hCG caused a decrease in GATA-4 mRNA expression (Heikinheimo et al. 1997). Ovarian
function is more dependent on gonadotropins than is testis function (Aittomaki et al. 1995). It has
been demonstrated that a mutation in the FSH receptor (FSHR) gene causes hereditary
hypergonadotropic ovarian failure, which results in infertility. In the male, lack of FSH function is
incompatible with testicular maturation and fertility (Tapanainen et al. 1997). Previously, FSH was
considered essential for pubertal initiation of spermatogenesis and maintenance of normal sperm
production in adults. However, males homozygous for an inactivating FSHR mutation suffer from
various degrees of spermatogenic failure, calling into question the essential role of FSH in the
initiation of spermatogenesis. In the ovary, the inactivating FSHR mutation (Ala189Val) results in
very low or negligible GATA-4 expression (Vaskivuo et al. 2002). It has been impossible to study
testicular GATA-4 expression in men with this FSHR mutation.
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8.3 Role of GATA and FOG factors in testicular function
8.3.1 GATA-4 regulating inhibin α gene (I)
The 5’ region of the mouse inhibin α gene has promoter activity essential for its function. This
region includes a pair of consensus GATA-binding sites between nucleotides -153 and -110 (Su
and Hsueh 1992). Mutation analysis of the GATA elements in rat inhibin α promoter demonstrated
that mutations of either one or both of the two GATA sites reduce basal and cAMP-stimulated
activity of the inhibin α promoter (Feng et al. 1998). Furthermore, in human and rodent testis,
inhibin α is expressed in Sertoli and Leydig cells overlapping with GATA-4 expression (Bhasin et
al. 1989, Tone et al. 1990, Eramaa et al. 1992, Majdic et al. 1997, Anderson et al. 2002) (I-IV). FSH and
LH are the main regulators of inhibin α in Sertoli and Leydig cells (Ying et al. 1986, Lee et al. 1989).
In those cells, FSH and LH slightly upregulate GATA-4, providing a plausible mechanism for
hormonal control of inhibin α expression.
Electrophoretic mobility shift analysis (EMSA) demonstrated that GATA-4 specifically binds to
both GATA sites of inhibin α promoter. When the first G on the GATA site was mutated to C,
binding activity was totally abolished (Figure 9, unpublished results). Furthermore, GATA-4
transactivated mouse inhibin α promoter in Leydig (mLTC-1) and granulosa (KK-1) tumor cell
lines in in vitro transactivation experiments (I) (Figure 10). Mutations of one or both of the GATA
binding sites of inhibin α promoter fully abolished GATA-4-induced transactivation. Results of in
vitro experiments do not necessarily reflect the physiological situation, but data from other studies
support a potential link between GATA-4 and the regulation of inhibin α gene in the testis.
Figure 9. GATA-4 binds to inhibin α promoter. Lane 1: EMSA
with 32P-labeled double-stranded inhibin α promoter oligonucleotide
(-155/-140) probe and 10 µg protein from nuclear extract of mouse
Sertoli cell tumor line (MSCFSHR-1). Lane 2: Super shift with
GATA-4 antibody. Lane 3: GATA-1 antibody. Lane 4: Mutated
GATA binding site of inhibin α promoter (G → C). Results were
identical with (-121/-104) inhibin α promoter oligonucleotide. Both
of these promoters contain GATA-binding sites.
All in all, findings on the temporal and spatial expression of GATA-4 and its hormonal regulation,
as well as results from transactivation reporter gene assays, support a potential link between
GATA-4 and regulation of inhibin α expression in testes.
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Other researchers have used another Leydig cell tumor line, MA-10, in corresponding
transactivation studies; their results reveal that GATA-1, but not GATA-4, transactivates rat
inhibin α promoter (Feng et al. 1998). Nucleotide sequences of inhibin α promoter of the mouse
and rat are very much alike, and sequences are identical between the two GATA sites (Su and
Hsueh 1992), meaning that species-specific differences in promoters do not explain differing
findings regarding inhibin α promoter activation. Two recent studies, however, may explain in part
these controversial findings on inhibin α promoter activation. Besides Sertoli cells, also Leydig
cells from 3-week-old juvenile rats expressed GATA-1 mRNA (Zhang et al. 2002),  whereas in adult
rat testis, only Sertoli cells expressed GATA-1 (Feng et al. 1998, Robert et al. 2002). These findings
and the gene transactivation studies suggest a role also for GATA-1 in the regulation of inhibin α
transcription, at least during certain periods of testicular development.
Besides gonadal cell lines, GATA-1 and GATA-4 transactivate inhibin α promoter in the CV-1 non-
gonadal cell line, and this observation provides another piece of evidence for roles for both
GATA-1 and GATA-4 in the regulation of inhibin α. African green monkey kidney cell line, CV-1,
expresses none of the GATA factors endogenously. In this cell line, both GATA-1 and GATA-4
transactivate inhibin α promoter (Tremblay and Viger 2001a, Robert et al. 2002). Because non-
gonadal cell lines such as CV-1 may lack other factors perhaps involved in inhibin α-signaling
pathways in the testis, interactions that otherwise modulate GATA-1 and GATA-4 activity in vivo
thus may be neglected. On the other hand, the activation of inhibin α gene by GATA-1 and GATA-
4 in CV-1 cells indicates that these factors directly activate inhibin α gene transcription.
8.3.2 FOG-1 and FOG-2 repression of inhibin α gene activation by GATA-4
Testicular GATA factors are expressed in a partially overlapping manner during testicular
development. The cell-specific differences in gene regulation by testicular GATA proteins may
well be explained by interactions between GATA-binding proteins and their cofactors. The most
Figure 10. Cotransfection of GATA-4 expression
vector (pMT2-G15A) and inhibin α promoter
Growth Hormone (GH) reporter plasmid
(pTKGH-inhibin) into mLTC-1 tumor cell lines.
Activation of inhibin α promoter by GATA-4 is
abolished by mutating the first (mut 1), second (mut
2), or first and second (mut 1&2) GATA sites of the
promoter. Bars indicate mean (±SEM) GH
concentration (ng/ml). ** P = 0.0001 (between GH
concentrations).
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notable are FOG proteins, which were originally identified as GATA-specific cofactors in yeast
two-hybrid analyses. FOG-1 and FOG-2 either enhance or repress the promoter activity of the
cardiac or hematopoietic genes regulated by GATA factors (Fossett and Schulz 2001, Cantor and
Orkin 2002). This provides a plausible mechanism for fine-tuning the expression of GATA-dependent
genes also in the testis.
The basal promoter activity of inhibin α is repressed by FOG-1 and FOG-2 in MSC-1 Sertoli cells
that endogenously express GATA-1 and GATA-4 (Robert et al. 2002). Furthermore, the
transcriptional activity of GATA-4 on the inhibin α promoter is restored when FOG proteins are
unable to interact with the N-terminal zinc-finger of GATA-4 in which the FOG binding site is
mutated. These in vitro experiments link FOG proteins to the regulation of the inhibin α gene,
together with GATA-1 and GATA-4.
Based on the expression patterns of GATA-1, GATA-4, FOG-1, and FOG-2 as well as of inhibin α,
it is plausible that FOG-1 interacts with GATA-4 during fetal testicular development, and it may
well suppress the activation of GATA-4 on the inhibin α gene. Inhibin α is first detected in fetal
mouse testis at E16, thus coinciding with the appearance of FOG-1 expression (Tone et al. 1990). In
postnatal Sertoli cells, FOG-1 expression coincides with that of GATA-1 from the appearance of
the first wave of spermatogenesis. Later, the number of FOG-1- and GATA-1-positive Sertoli cells
declines, and in adult seminiferous tubules, these factors are predominantly expressed in stage
VII-XII tubules. Thus, FOG-1 may well repress GATA-1 activity during postnatal testicular
development.
Mice deficient in inhibin α develop testicular tumors with nearly 100% penetrance, suggesting a
role for inhibin α as a tumor suppressor (Matzuk et al. 1992). Inhibin α and inhibin β-B chains form
inhibin B that is endocrinologically the most important form of inhibin in men (Anawalt et al. 1996,
Illingworth et al. 1996). Interestingly, in gonadal cell lines, not only inhibin α, but also the inhibin
β-B-subunit is regulated by GATA-1 and GATA-4 (Feng et al. 2000). These findings further
underscore the importance of GATA-4 in the regulation of the inhibin pathway essential for
normal gonadal development and function.
8.3.3 GATA-4 and FOG-2 required for early testicular development
In vivo studies provide the most convincing evidence for the essential nature of GATA-4 and
FOG-2 in testicular development. In mice, abrogation of GATA-4/FOG-2 interaction or abolition of
the FOG-2 gene (with FOG-2 function partially rescued) results in abnormalities in gonadogenesis
(Tevosian et al. 2002). Testes fail to develop probably due to insufficient SRY expression, and as
a consequence, Sertoli cell differentiation is blocked, which in turn results in the absence of
testicular cords. Leydig cells are present, but the steroidogenic program is not initiated, due to
ectopic WNT-4 expression. These results do not directly indicate that GATA-4 and/or FOG-2
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regulate SRY expression. In the absence of Sertoli and Leydig cells and their gene products, it is
impossible to assess their role in subsequent events in testicular development and spermatogenesis.
However, their presence and physical interaction in the genital ridge are required for normal
testicular differentiation. In these mice, the rescue of SRY function may be a valuable tool to better
reveal the role of GATA-4 and FOG-2 in testis development and function.
In the present animal model, testicular development was blocked before Sertoli cell differentiation,
and as a consequence such genes as MIS and SOX-9 were not expressed. It was impossible,
therefore, to evaluate the impact of GATA-4/FOG-2 interactions on those genes expressed after
SRY expression. Taken that, after testicular differentiation, FOG-2 is downregulated and FOG-1 is
upregulated the latter would be the gene of interest “as a friend of GATA-4” in the development of
the late fetal testis. In the ovary, GATA-4 and FOG-2 are expressed throughout the fetal period, but
the ovarian phenotype of these mutant mice is to be described on later (Tevosian et al. 2002).
8.3.4 Several gonadal genes regulated by GATA-4 and FOG proteins
Besides inhibin α, several other gonadal genes, such as MIS, SF-1, StAR (Steroidogenic acute
regulatory protein), and aromatase contain GATA motifs in their promoters (Tremblay and Viger
2001a). StAR and aromatase are enzymes essential for normal steroidogenesis, which in turn is
required for gonadal development and adult spermatogenesis (Carreau et al. 2001, Conley and
Hinshelwood 2001, Stocco 2001, Stocco 2002).  GATA-4 activates all of these genes in in vitro
assays (Figure 10). The role of GATA-4 in the regulation of MIS has received the most intensive
study. GATA-4 activates the MIS promoter on its own (Viger et al. 1998) and interacts with SF-1
through complex mechanisms to activate the MIS transcription (Tremblay and Viger 1999, Watanabe
et al. 2000, Tremblay et al. 2001, Tremblay and Viger 2001a). Furthermore, on the MIS promoter,
FOG-1 and FOG-2 repress GATA-4 activity and GATA-4/SF-1 synergism (Tremblay et al. 2001,
Robert et al. 2002, Anttonen et al. 2003). Dax-1 also disrupts transcriptional synergism between
GATA-4 and SF-1, resulting in repression of MIS transcription (Tremblay and Viger 2001b). The
role of GATA-4 in MIS gene activation is growing more complex, taken that GATA-4 activates SF-
1 also (Tremblay and Viger 2001a).
This activation or repression of MIS occurs through a complex interplay between transcription
factors and accessory proteins. The interactions of GATA-4, SF-1, FOG-1, and FOG-2 do not limit
the MIS gene only. Results from recent studies have shown that GATA-4 interacts with SF-1 and
FOG proteins to regulate not only MIS but also StAR, aromatase, and inhibin α genes. SF-1
interacts with GATA-4 to promote StAR, aromatase, and inhibin α transcription (Tremblay and
Viger 2001a, Robert et al. 2002), and FOG proteins repress transcriptional activity (Robert et al.
2002, Tremblay et al. 2002). These congruent results in in vitro studies suggest that GATA-4
regulates gonadal development and function at various levels, together with other factors such as
FOG proteins.
Results and Discussion
50
Human studies indirectly support the in vitro data on GATA-4-induced gene activation. Leydig
cells are the major source of testosterone, and the StAR gene is expressed in fetal and adult Leydig
cells. GATA-4 expression in fetal Leydig cells was most intensive before midgestation (II, IV)
when fetal testosterone production peaks (Tapanainen et al. 1981). In addition, the initiation of
testosterone production at puberty coincides with upregulated GATA-4 expression in Leydig
cells. Overlapping expression patterns of GATA-4 and StAR in Leydig cells and the results from
transactivation studies strongly suggest that GATA-4 regulates testosterone biosynthesis also
in vivo.
Taken together, the results from in vitro and in vivo studies clearly demonstrate that GATA-4
plays an important role in the testis by participating in regulation of several key molecules during
testicular development (Figures 11 and 12). Not only GATA-4, but also GATA-1 and GATA-6 are
most likely to play a role in the regulation of gene expression of the testis. They were capable of
activating multiple gonadal genes such as MIS, inhibin α, and StAR. This activity was enhanced
by simultaneous expression of SF-1 and repressed by FOG-1 and FOG-2 (Robert et al. 2002). Cell-
specific temporal and spatial expression patterns of GATA and FOG proteins will ultimately identify
their target genes expressed during testicular development. Furthermore, their individual affinities
for various promoters are likely to modify the expression of their target genes (section 5.4.1).
Figure 11. Genes (grey boxes) regulated by GATA-4 and FOG-1 or FOG-2 during fetal testicular
development. Crossed-out FOG-2 means disappearing Sertoli cell expression. Inhα,  Inhibin α.
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8.3.5 The role of GATA-4 in hypothalamus and pituitary
Within the hypothalamic-pituitary-gonadal axis, the expression of GATA and FOG proteins is not
restricted to the gonads. GATA-4 is expressed in the mouse pituitary (Heikinheimo and Wilson,
unpublished results) and in migrating GnRH neurons (Lawson and Mellon 1998). In the pituitary-
derived cell line T3-1, GATA-binding protein regulates the gonadotropin α-subunit gene (Steger
et al. 1994), a common subunit both of FSH and of LH (Griffin and Wilson 1998). In the GnRH-
secreting hypothalamic neuronal cell line GT1, GATA-4 regulates the activity of the GnRH gene
(Lawson et al. 1996, Lawson et al. 1998, Lawson and Mellon 1998). These findings strongly
suggest that GATA-4 plays a functional role also in the hypothalamus and pituitary. Furthermore,
FOG proteins may act as GATA-4 cofactors, since both FOG-1 and FOG-2 are expressed in the
brain (Tsang et al. 1997, Lu et al. 1999, Svensson et al. 1999, Tevosian et al. 1999). Their cell-specific
expression has not been addressed in detail, but based on previous studies one might expect that
Figure 12. Summary of the essential sites of GATA-4 action in the fetal testis.
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FOGs share an overlapping expression pattern with GATA-4. The interaction of FOG-2 with GATA-
4 is necessary for the development of the heart and gonads (Crispino et al. 2001, Tevosian et al.
2002). It is therefore plausible that FOG-2 has a role, along with GATA-4, also in the development
and function of pituitary and/or hypothalamus. Thus, GATA and FOG proteins are likely to act at
various sites of the hypothalamic-pituitatary-gonadal axis.
8.3.6 Apoptosis and cell proliferation in fetal human testis (IV)
Apoptotic cell death plays a major role in the regulation of testicular function (Griswold 1998,
Matsui 1998, Beumer et al. 2000, Kierszenbaum and Tres 2001). GATA-4 and GATA-6 are abundantly
expressed in the testis and are involved in apoptotic processes of various tissues from the fetal
period onwards. It is thus plausible that they are involved in apoptotic cell death also in fetal
testis. Proper tissue development requires a balance between cell death and proliferation. Both
GATA-4 and GATA-6 have also been linked to cell proliferation (Grepin et al. 1997, Perlman et al.
1998, Nagata et al. 2000). We therefore sought any spatial and temporal relationships between
GATA-4 and GATA-6 expression, apoptosis, and the apoptosis-related proteins bcl-2 and bax
during human fetal testicular development (IV). Cell proliferation was assessed in the same samples
by means of anti-Ki-67 antibody and immunohistochemical analyses (IV).
GATA-1, GATA-4, and GATA-6, respectively, are linked to the regulation of apoptosis in the red
blood cells, in the ovary, and in colorectal carcinoma cells. Caspase-mediated degradation of
GATA-1 results in apoptotic death of maturing red blood cells, and it may represent a negative
control mechanism in erythropoiesis (De Maria et al. 1999, Orkin and Weiss 1999). In the human
ovary, the expression pattern of GATA-4 suggests that, from fetal to adult life, it is involved in the
mechanisms protecting granulosa cells from apoptosis (Vaskivuo et al. 2001). GATA-4 expression
was at its highest level in the youngest fetal ovaries and decreased towards term, parallel with
apoptotic oocyte death. Similarly, GATA-4 downregulation precedes apoptotic cell death of
granulosa cells in the mouse ovary (Heikinheimo et al. 1997). In colorectal cancer cells, nonsteroidal
anti-inflammatory drugs down-regulate GATA-6, which results in up-regulation of 15-lipoxygenase-
1 and induction of the apoptosis of these cancer cells (Shureiqi et al. 2002).
In fetal testis, a TUNEL assay revealed apoptotic cell death in both the testicular cords and
interstitium from the second trimester to term (IV). The overall number of apoptotic cells was low,
and these cells were distributed equally between somatic and germ cell lineages. After midgestation,
there occurred a temporary peak in Sertoli cell apoptosis. The number of apoptotic Sertoli cells
rose markedly, but then returned to a low level during the third trimester. Proliferative activity was
the most intense at the beginning of the second trimester. The cells with the most active proliferation
rate as measured by Ki-67 immunohistochemistry were predominantly Leydig cells. Beginning
from midgestation, proliferation diminished gradually with advancing gestational weeks and ceased
totally at term.
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Bcl-2 protein was expressed in the Leydig and peritubular myoid cells between fetal weeks 16 and
23 (IV). Bcl-2 was no longer detectable in any testicular cell compartment by week 27. The expression
of bax differed markedly from that of bcl-2; abundant cytoplasmic bax expression was detected
both in testicular cords and in the interstitium from weeks 16 until term. Peritubular myoid cells
expressed no bax protein at any fetal age.
The overall rate of apoptosis and proliferation in the fetal testis was low throughout all gestational
weeks (weeks 16 to 40). These results indicate that the major portion of testicular cell proliferation
occurs before the second trimester. This is in agreement with previous findings implying that
Sertoli, Leydig, and germ cell proliferation is most intensive during the first trimester (Wartenberg
1978, Codesal et al. 1990). Thus, before midgestation, human fetal testis seems to reach a quiescent
balance between cell proliferation and apoptosis.
Sertoli cell apoptosis was at its highest level at the end of the second trimester (IV). This may
reflect the effect of declining serum FSH levels on Sertoli cells (Kaplan et al. 1976). It has been
proposed that the number of Sertoli cells decreases rather than increases from the second trimester
to term (Helal et al. 2002). The temporarily enhanced apoptosis of the Sertoli cells after midgestation
provides a possible mechanism for declining Sertoli cell number. Leydig cell proliferation was
observed before midgestation (IV) when testicular androgen production peaks (Tapanainen et al.
1981). Since GATA-6 activates steroidogenic enzyme genes (Robert et al. 2002), and the hormonally
active Leydig cells do not proliferate (Murray et al. 2000), GATA-6 expression may be linked to
testosterone synthesis rather than to cell proliferation.
Expression patterns of GATA-4 and GATA-6 failed to match the patterns of apoptosis or cell
proliferation (II, IV), meaning that in human fetal testis, these GATA factors are unlikely to be
involved in either bcl-2-/bax-mediated pro-/anti-apoptotic processes or in mechanisms regulating
cell proliferation. However, that the expression of GATA-4 is downregulated prior to granulosa cell
apoptosis in fetal mouse ovary (Heikinheimo et al. 1997) indicates that GATA-4 may play a role in
regulating apoptosis in the ovary.
In human fetal testis, Bcl-2 expression changes in a cell-specific manner along with testicular
development (IV) (Quenby et al. 1999, Murray et al. 2000) (Table 11). During the first trimester, this
anti-apoptotic protein is expressed in the Sertoli and Leydig cells. At the beginning of the second
trimester, bcl-2 is detected in the Leydig and myoid cells. Thus, bcl-2 expression coincides with
major testicular morphogenetic and developmental changes, and bcl-2 may protect somatic cell
types from apoptosis during their proliferation and maturation. During the second trimester,
testicular development reaches a quiescent steady state level, and bcl-2 is no longer needed or,
alternatively, other factors fulfill its function.
The number of apoptotic cells was low even in the presence of abundant bax protein (IV). Because
bax protein activity is dependent on its intracellular localization (Hsu et al. 1997, Wolter et al. 1997,
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Zamzami et al. 1998, Putcha et al. 1999), intense bax expression does not necessarily reflect the
amount of biologically active bax protein. Alternatively, in fetal testis, anti-apoptotic factors such
as bcl-x counterbalance bax (Rucker et al. 2000). Loss of bcl-x function induced germ-cell loss
through enhanced apoptosis even during the fetal perioid, and spermatogonia were not detectable
postnatally. Loss of bcl-x function was corrected by deletion of the bax gene, which resulted in a
restoration of germ cell survival. In contrast, bax-deficient mice have an excessive number of
spermatogonia in the maturing postnatal testis (Russell et al. 2002). Overproduction of
spermatogonia blocks the normal maturation of spermatocytes that eventually results in bax-
independent germ-cell death and in testicular atrophy in adults. Bax-dependent apoptosis therefore
probably serves a major purpose during postnatal testis development and is required for functional
spermatogenesis (Rodriguez et al. 1997, Yan et al. 2000b, Russell et al. 2002).
Table 11. Summary of bcl-2 and bax expression in human fetal testis. Bax expression not addressed
before gestational week 13. (Data from IV, Quenby et al. 1999, and Murray et al. 2000).
8.4 GATA-4 and diseases of human testis
8.4.1 Developmental disorders (II)
Developmental testicular diseases represent a heterologous group of disorders. Defects range
from testicular agenesis to normal virilization but reduced fertility. Given the emerging role of
GATA-4 in the development and gene regulation of mammalian testis, we wanted to elucidate the
role of GATA-4 in human developmental diseases of the testis. Expression of GATA-4 protein was
explored by immunohistochemistry in testis samples from patients with androgen resistance,
cryptorchidism, Kallman’s syndrome, or Sertoli-cell only syndrome (II, unpublished results).
Expression of GATA-4 was studied in testis samples from patients who underwent orchidectomy
due to androgen resistance (II). Staining intensity in Sertoli cells and spermatogonia was either
very weak or totally absent and decreased along with advancing age from 1 to 14 years. Leydig
cells were mainly negative for GATA-4. The overall expression of GATA-4 was lower than in
normal testes (Table 12). No difference existed in GATA-4 expression between testicular samples
from patients with partial or with complete androgen resistance.
In patients with androgen resistance, the impact of androgens is reduced due to defects in the
androgen receptor or to lack of the 5αreductase enzyme which metabolizes testosterone to
dihydrotestosterone (DHT). This disorder of androgen action is the main cause of male
pseudohermaphroditism (Sultan et al. 2002). Testes of these patients may develop normally, whereas
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differentiation of the Wolffian ducts, urogenital sinus, and external genitalia is androgen dependent.
Abnormalities in these derivatives therefore occur in androgen resistance, and it may result in
sexual ambiguity, i.e., genitalia typical of neither male or female. Testicular morphology also varies
considerably between androgen-resistant patients; testes may develop normally or resemble
“testes-like structures” with clusters of Sertoli and Leydig cells.
Testes of androgen-resistant patients secrete testosterone normally. The reduced GATA-4
expression in their Sertoli cells is thus likely to be related to their defective response mechanism
for androgen stimulus. In other words, testosterone and DHT have no direct effect on GATA-4
expression; their effects are mediated through indirect mechanisms. The actions of testosterone
and DHT are mediated via the AR that is coexpressed with GATA-4 in Sertoli, Leydig, and myoid
cells (Suarez-Quian et al. 1999, Zhou et al. 2002). The gene for AR also has putative GATA-binding
sites on its promoter (Song et al. 1993, Mizokami et al. 1994). Thus, GATA-4 may well regulate the
expression of androgen receptors in the testis. In the Sertoli cells of androgen-resistant patients,
reduced GATA-4 expression may diminish the expression of its downstream target genes such as
MIS, which in turn may have effects on the development of diverse sexual phenotypes.
Patients with cryptorchidism underwent surgery on their unilateral or bilateral undescended
testes with or without preceding hCG treatment (II). In cryptorchid testes, GATA-4 immunoreactivity
was present in Sertoli cells and spermatogonia but was very weak in or absent from Leydig cells
(Table 12). These findings are comparable to the expression pattern in normal testes. GATA-4 is
therefore unlikely to play a role in the pathogenesis of cryptorchidism. Furthermore, the treatment
used, the localization of the testis, and the period from treatment to biopsy had no effect on
GATA-4 expression in any of the testicular cell types.
In the adult patient with Kallman’s syndrome, Sertoli and Leydig cells were positive but
spermatogonia were negative for GATA-4 (II). This expression pattern was similar to that of
normal testes, but the staining intensities in Sertoli and Leydig cells appeared weaker than normal
(Table 12). In testicular samples from the patient with Sertoli-cell-only syndrome (SCOS), GATA-
4 was expressed in Sertoli and Leydig cells as in the controls or the expression was slightly
reduced (unpublished results). SCOS is a syndrome of unknown etiology in which spermatogenesis
is impaired, and it results in azoospermia and infertility (Anniballo et al. 2000). Due to the low
number of testicular samples of Kallman’s syndrome and SCOS, it is impossible to reach definitive
conclusions as to GATA-4 expression and pathogenesis in these diseases.
Table 12. Intensity of GATA-4 expression in samples from human testicular diseases compared to
normal age-matched control samples. Number of samples in parentheses.
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8.4.2 Tumors (II)
Enhanced or persistent expression of GATA-4 has been reported in non-gonadal tumors, including
adrenocortical carcinomas, esophageal/gastric adenocarcinomas, and yolk sac tumors (Kiiveri et
al. 1999, Siltanen et al. 1999, Lin et al. 2000), suggesting a role for GATA-4 in the progression of
these neoplasms. Furthermore, GATA-4 was expressed in tumors of gonadal origin, including
ovarian sex-cord and testicular yolk sac tumors (Siltanen et al. 1999, Laitinen et al. 2000). Given
that GATA-4 is abundantly expressed in the testis from the fetal period to adulthood, the expression
of GATA-4 in testicular tumors was analyzed by immunohistochemical staining (II).
Human Sertoli tumor cells exhibited very intense expression of GATA-4 in testis samples from a 12-
year-old boy with a Sertoli cell tumor (Large-cell calcifying Sertoli cell tumor). The staining
intensity of the tumor cells was clearly stronger than of Sertoli cells of the adjacent healthy
tubules. This finding was consistent in all affected tubuli. Upregulation of GATA-4 expression
was also evident in all five patients’ Leydig cell tumors, in which GATA-4 was abundantly
expressed in tumor cells. Unaffected Leydig and Sertoli cells in these tumors stained like the
control samples. In contrast to the findings for Sertoli and Leydig cell tumors, no GATA-4 was
detected in any of the six germ-cell-derived seminomas analyzed (unpublished results) (Table 13).
High GATA-4 expression may be due either to the processes leading to tumor formation or be
induced after tumor transformation. Within the endocrine system, GATA-4 may play a role in
tumorigenesis of the adrenal gland (Kiiveri et al. 1999). Transgenic mice that develop adrenocortical
tumors exhibit abundant GATA-4 expression in their malignant adrenocortical cells, whereas normal
adrenocortical cells are devoid of GATA-4. Such a difference, accompanied by tumorigenesis and
the expression of GATA-4 has not, however, been detected in gonads. Besides testicular tumors,
GATA-4 is expressed in ovarian granulosa and theca cell tumors, i.e., tumors arising from ovarian
counterparts for testicular Sertoli and Leydig cells, respectively (Laitinen et al. 2000). Given that
GATA-4 is abundantly expressed in granulosa, theca, Sertoli, and Leydig cells during normal
development, it is unlikely that GATA-4 alone initiates tumor growth in gonadal somatic cells. On
the other hand, GATA-4 may promote the growth of testicular and ovarian tumors. In the ovary,
downregulation of GATA-4 precedes the granulosa cell atresia that occurs via apoptotic cell death
(Heikinheimo et al. 1997). Therefore, their abundant GATA-4 expression may inhibit apoptosis in
gonadal tumor cells and thus promote tumor growth.
Given the intense GATA-4 expression during the proliferative phase of Sertoli cells (I, II, III) (Viger
et al. 1998), GATA-4 may influence cell proliferation also in Sertoli cell tumors. Alternatively,
GATA-4 may participate in enhanced hormone production by the tumor cells. Inhibin subunits
shown to be regulated by GATA-1 and GATA-4 (Feng et al. 1998, Feng et al. 2000) (I), are abundantly
expressed in Sertoli tumor cells, and serum inhibin levels are elevated (Toppari et al. 1998). Thus,
GATA-4 may regulate the production of inhibin α and βB-subunits in Sertoli cell tumors. Leydig
cell tumors are hormonally active and produce testosterone or estradiol (Griffin and Wilson 1998).
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The biosynthesis of these hormones is controlled by StAR and aromatase, which in turn are both
regulated by GATA-4 (Silverman et al. 1999, Tremblay and Viger 2001a). It can therefore be proposed
that GATA-4 expression is linked to hormone secretion also in Leydig cell tumors.
No direct evidence allows us to draw conclusions as to causality between GATA-4 expression and
tumorigenesis. However, GATA-4 regulates putative tumor suppressor genes such as MIS and
inhibin α (section 8.3) (Matzuk et al. 1992, Matzuk et al. 1995). Loss of the activity of these genes
results in testicular tumor growth. Interestingly, one of the allelles of the GATA-4 gene appeared
to be lost in serous ovarian carcinomas (Lassus et al. 2001). These tumors arise from the surface
epithelium of the ovary where GATA-4 is normally expressed. Loss of the GATA-4 gene suggests
that GATA-4 possesses either direct or indirect tumor suppressor activity in specific gonadal
tumors.
Table 13. Expression of GATA-4 in gonadal tumors. Number of GATA-4 positive tumors of all tumors
studied in parenthesis.
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Conclusions
9 CONCLUSIONS
Gene expression data, as presented herein, provide an important resource for defining gene function
and for identifying hierarchies and networks of genes that regulate specific developmental programs.
It does not allow us to reach definitive conclusions as to the interactions of various developmental
factors. However, it gives us a physiological backbone for evaluating the results of in vitro
studies. Moreover, it helps us to focus further studies on understanding and clarifying the role of
GATA and FOG proteins during testicular development.
Testicular development requires temporally and spatially controlled expression of a number of
genes. Some of these genes are expressed for only a limited period of time, whereas others form a
network that regulates not only fetal but also postnatal development and function. This study
elucidated the expression of transcription factors GATA-1, GATA-4, and GATA-6. These are
expressed in a distinct but partially overlapping manner in the developing testis, and their
expression patterns indicate that they may be important regulators of testicular development and
function. Their cofactors, FOG-1 and FOG-2, are likely to modulate their actions depending on the
cellular context of any given factor(s). FOG-2 may act with GATA-4 during the earliest stages of
testicular development; later in the fetal testis, FOG-1 functions as a cofactor for GATA-4. In adult
testis, GATA-1 and FOG-1 are likely to be the interacting partners.
This study revealed that GATA-4 is hormonally regulated, but neither gonadotropin nor androgen
action is required for its basal expression. Furthermore, in gonadal cell lines, GATA-4 upregulates
the inhibin α gene. Others have shown that GATA-4 regulates a number of other genes such as
MIS and StAR that are important for testicular function. GATA-4 is also essential for proper
expression of the SRY gene, implying a role for this transcription factor in the earliest steps of
testiculogenesis. All these findings together indicate that GATA-4 may be one of the master
regulators of testicular development and function.
In addition to the gonads, members of the GATA family of transcription factors are expressed at
various sites within the endocrine system. They regulate reproductive functions along the
hypothalamic-pituitary-gonadal axis. Furthermore, GATA proteins are already being expressed at
the earliest stages of development in the adrenals and pancreas; both organs are essential for
normal hormonal homeostasis and eventually for the survival of the individual. Therefore, based
on the results of previous and current studies, the GATA family may play a non-redundant and
essential role in a number of different endocrine organs.
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